Product Name | Peptide Sequence |
---|---|
MBP (4-14), bovine, MBP (3-13), mouse | QKRPSQRSKYL |
MBP (69-85), guinea pig | YGSLPQKSQRSQDENPV |
MBP (85-98), guinea pig, MBP (86-99), human, MBP (83-96) mouse | VVHFFKNIVTPRTP |
MBP (85-106) guinea pig, MBP (86-107), human | VVHFFKNIVTPRTPPPSQGKGR |
MBP (84-96), mouse, MBP (86-98), guinea pig, MBP (87-99), human | VHFFKNIVTPRTP |
MBP (88-104), guinea pig, MBP (89-105), human, MBP (86-102), mouse | Ac-FFKNIVTPRTPPPSQGK-NH2 |
MBP MAPK Substrate | APRTPGGRR |
Biotin-LC-MBP Derivatized Peptide | Biotin-LC-FFKNIVTPRTPPPSQGK-NH2 |
Myosin H Chain Fragment, mouse | Ac-RSLKLMATLFSTYASADR |
Nesfatin-1 (24-53), human | PDTGLYYDEYLKQVIDVLETDKHFREKLQK-NH2 |
Nesfatin-1 (24-53), mouse | PDTGLYYDEYLKQVIEVLETDPHFREKLQK-NH2 |
biotin-Neurogranin (48-76), human | Biotin-SGERGRKGPGPGGPGGAGVARGGAGGGPS |
biotin-Neurogranin (48-76), mouse | Biotin-SGECGRKGPGPGGPGGAGGARGGAGGGPS |
Neurogranin (48-76), human | SGERGRKGPGPGGPGGAGVARGGAGGGPS |
Neurogranin (48-76), mouse | SGECGRKGPGPGGPGGAGGARGGAGGGPS |
Glutamate Receptor Endocytosis Inhibitor, GluR23Y | YKEGYNVYG |
LCMV GP61 | GLNGPDIYKGVYQFKSVEFD |
LCMV NP396 H-2Db peptide | FQPQNGQFI |
MOG (44-54), mouse, human, rat | FSRVVHLYRNG |
Neuropeptide S, NPS, human | SFRNGVGTGMKKTSFQRAKS |
Neuropeptide S, NPS, mouse | SFRNGVGSGAKKTSFRRAKQ |
P0 (180-199) | Peripheral Myelin P0 Protein (180-199), mouse |
P2 (53-78) | Peripheral Myelin Protein P2 (53-78), bovine |
Secretoneurin | TNEIVEEQYTPQSLATLESVFQELGKLTGPSNQ |
IKKγ NEMO Binding Domain (NBD) Inhibitory Peptide | DRQIKIWFQNRRMKWKKTALDWSWLQTE |
NF-kB Inhibitor, SN50 | AAVALLPAVLLALLAPVQRKRQKLMP |
Orexin B, human | RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 |
Orexin B, mouse | RPGPPGLQGRLQRLLQANGNHAAGILTM-NH2 |
[Gla17,21,24]-Osteocalcin (1-49) | YLYQWLGAPVPYPDPL-Gla-PRR-Gla-VC-Gla-LNPDCDELADHIGFQEAYRRFYGPV (Gla=γ-Carboxyglutamic Acid; Disulfide bridge: 23-29) |
Des-gamma-carboxylated Osteocalcin/Bone Gla Protein | YLYQWLGAPVPYPDPLEPRREVCELNPDCDELADHIGFQEAYRRFYGPV (Disulfide bridge:C23-29) |
OVA (241-270) | SMLVLLPDEVSGLEQLESIINFEKLTEWTS |
OVA (257-264) | SIINFEKL |
OVA (257-264), amide | SIINFEKL-NH2 |
OVA (257-264), FAM labeled | 5-FAM-SIINFEKL-NH2 |
OVA (257-264), scrambled, FILKSINE | FILKSINE |
OVA (323-339) | ISQAVHAAHAEINEAGR |
OVA (323-339), amide | ISQAVHAAHAEINEAGR-NH2 |
OVA (323-339), biotin-labeled | Biotin-ISQAVHAAHAEINEAGR |
OVA (323-339), FITC-labeled | FITC-LC-ISQAVHAAHAEINEAGR |
OVA (323-339), TAMRA labeled | 5-TAMRA-ISQAVHAAHAEINEAGR |
OVA (329-337) | AAHAEINEA |
OVA-A2 Peptide, SAINFEKL, OVA (257-264) Variant | SAINFEKL |
OVA-G4 Peptide, SIIGFEKL, OVA (257-264) Variant | SIIGFEKL |
OVA-Q4 Peptide, pQ4, SIIQFEKL, OVA (257-264) Variant | SIIQFEKL |
OVA-Q4H7 Peptide, pQ4H7, SIIQFEHL, OVA (257-264) Variant | SIIQFEHL |
OVA-T4 Peptide, SIITFEKL, pT4, OVA (257-264) Variant | SIITFEKL |
Aquaporin-2 (254-267), pSER261, human | RQSVELH-pS-PQSLPR |
[Lys(Ac)382]-p53 (361-393), biotin labeled, amide, human | Biotin-LC-GSRAHSSHLKSKKGQSTSRHK-K(Ac)-LMFKTEGPDSD-NH2 |
[Lys(Ac)382]-p53 (372-389), biotin labeled | Biotin-LC-KKGQSTSRHK-K(Ac)-LMFKTEG |
p53 (17-26) | ETFSDLWKLL |
TP53 Q9NP68, p53 Mutant Form (372-389), Lys382 (Ac) | KKGQSTSRHK-K(Ac)-LMFKTEG |
Parathyroid Hormone (1-13) | SVSEIQLMHNLGK |
Parathyroid Hormone (1-34), human | SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF |
Parathyroid Hormone (1-34), human, biotinylated | Biotin-SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF |
Parathyroid Hormone (1-34)-Lys(Biotin), human | SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFK(Biotin) |
TIP 39, Tuberoinfundibular Neuropeptide | SLALADDAAFRERARLLAALERRHWLNSYMHKLLVLDAP |
Ala-γ-D-Glu-DAP | A-(γ-e)-DAP |
Keratin K18-C | RPVSSAApSVYAGAC |
Threonine Phosphopeptide,PKC Substrate 4, phosphorylated | KR-pT-IRR |
UOM9, PKC Substrate, phosphorylated | KRP-pS-QRHGSKY-NH2 |
Phytochelatin 2, PC2 | (γE-C)2-G |
Phytochelatin 3, PC3 | (γE-C)3-G |
Phytochelatin 4, PC4 | (γE-C)4-G |
Phytochelatin 5, PC5 | (γE-C)5-G |
Phytochelatin 6, PC6 | (γE-C)6-G |
PrP (106-126) | KTNMKHMAGAAAAGAVVGGLG |
Calpain Inhibitor Peptide, B27-WT | DPMSSTYIEELGKREVTIPPKYRELLA |
[Ser140]-PLP (139-151) | HSLGKWLGHPDKF |
PLP (139-151) | HCLGKWLGHPDKF |
PLP (178-191) | NTWTTCQSIAFPSK |
PLP (180-199) | WTTCQSIAFPSKTSASIGSL |
ε-V1-2, ε-PKC Inhibitor | EAVSLKPT |
Abltide | KKGEAIYAAPFA-NH2 |
AMARA peptide | AMARAASAAALARRR |
Bovine β-Casein, monophosphopeptide | FQ-pS-EEQQQTEDELQDK |
Cathepsin D and E FRET Substrate | Mca-GKPILFFRLK(Dnp)-r-NH2 |
Cathepsin K substrate | Abz-HPGGPQ-EDDnp |
CDK7/9 tide | YSPTSPSYSPTSPSYSPTSPSKKKK |
DNA-PK Substrate | EPPLSQEAFADLWKK |
epsilon-V1-2, epsilon-PKC Inhibitor, Cys-conjugated | EAVSLKPTC |
Erktide | IPTTPITTTYFFFK |
Forkhead derived peptide, Woodtide | KKISGRLSPIMTEQ-NH2 |
GSK3 Substrate, a, b subunit | RAAVPPSPSLSRHSSPHQSEDEEE |
IRS1-derived peptide | KKSRGDYMTMQIG-NH2 |
Jak3tide | GGEEEEYFELVKKKK |
MLC-derived peptide | KKRPQRRYSNVF |
Myristolated PKC Zeta, Pseudosubstrate (ZIP) | Myr-SIYRRGARRWRKL |
Myristolated PKC Zeta, Pseudosubstrate ZIP, Scrambled | Myristoyl-RLYRKRIWRSAGR |
PDKtide | KTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC |
Psi-RACK, epsilon-C2/V1 (82-92), epsilon PKC (82-92), C2 Domain | HDAPIGYD |
RS domain derived peptide | GRSRSRSRSR |
S3 Fragment, ADF/cofilin | MASGVMVSDDVVKVFN |
SAMS Peptide | HMRSAMSGLHLVKRR-NH2 |
Src Optimal Peptide Substrate | AEEEIYGEFEAKKKK |
Renin FRET Substrate I | DABCYL-g-Abu-IHPFHLVIHT-EDANS |
Renin Substrate, human | DRVYIHPFHLVIHN |
IRBP (1-20), human | GPTHLFQPSLVLDMAKVLLD |
IRBP derived peptide, R16 | ADGSSWEGVGVVPDV |
IRBP, Interphotoreceptor Retinoid Binding Protein Fragment | SGIPYIISYLHPGNTILHVD |
GRGDS | GRGDS |
GRGDSP | GRGDSP |
GRGDSPK | GRGDSPK |
GRGDTP | GRGDTP |
Prototype of RGD-containing peptide, FITC-labeled | FITC-LC-GRGDSP |
RGDS | RGDS |
Prosaptide TX14(A) | TaLIDNNATEEILY |
Dyrktide | RRRFRPASPLRGPPK |
JAG-1 (188-204), Jagged-1 (188-204), Notch Ligand, DSL Peptide | CDDYYYGFGCNKFCRPR |
M13 Skeletal Muscle Myosin Light Chain Kinase Peptide, SK-MLCK M13 | KRRWKKNFIAVSAANRFKKISSSGAL |
Pannexin-1 (Panx1), Mimetic Blocking Peptide | WRQAAFVDSY |
Scrambled Jag1 | RCGPDCFDNYGRYKYCF |
Steroid Receptor Co-Factor Peptide | LTERHKILHRLLQE |
Steroid Receptor Coactivator-1 (SRC-1), (676-700), biotin labeled | Biotin-CPSSHSSLTERHKILHRLLQEGSPS |
Steroid Receptor Coactivator-1, SRC-1 (686-700) | RHKILHRLLQEGSPS |
TET 830 modified/T-helper epitope from tetanus toxoid | AQYIKANSKFIGITEL |
TIF2 (740-753), Transcriptional Intermediary Factor 2 (740-753) | KENALLRYLLDKDD |
W Peptide, WKYMVm-NH2 | WKYMVm-NH2 |
WRW4, Formyl Peptide Receptor-Like 1 (FPRL1) Antagonist | WRWWWW |
Spexin (36-49), amidated, human/mouse/rat | NWTPQAMLYLKGAQ-NH2 |
Spexin-2 (53-70), amidated, human/mouse/rat | FISDQSRRKDLSDRPLPE-NH2 |
Spexin-2 (53-70), human/mouse/rat | FISDQSRRKDLSDRPLPE |
3 x Hemagglutinin (HA) Tag | MEYPYDVPDYAAEYPYDVPDYAAEYPYDVPDYAAKLE |
DYKDDDDK | DYKDDDDK |
Glu-Glu epitope Tag | EYMPME |
HA 12CA5 Epitope | CYPYDVPDYA |
HA peptide | YPYDVPDYA |
Hexa His | HHHHHH |
Rhodopsin Epitope Tag | TETSQVAPA |
V5 Epitope Tag | GKPIPNPLLGLDST |
Tau Peptide (45-73) (Exon 2/Insert 1 domain) | ESPLQTPTEDGSEEPGSETSDAKSTPTAE |
Tau Peptide (244-274) (Repeat 1 domain) | Ac-QTAPVPMPDLKNVKSKIGSTENLKHQPGGGK |
Tau Peptide (275-305) (Repeat 2 domain) | VQIINKKLDLSNVQSKCGSKDNIKHVPGGGS |
Tau Peptide (306-336) (Repeat 3 domain) | VQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQ |
Tau Peptide (337-368) (Repeat 4 domain) | VEVKSEKLDFKDRVQSKIGSLDNITHVPGGGN |
[Ser(OGlcNAc)]400-KWK-Tau (388-411)-KK(Biotin)-NH2 | KWKHGAEIVYKSPVV-S(OGlcNAc)-GDTSPRHLSNVK-K(biotin)-NH2 |
Thrombin Receptor Agonist,amide (SFLLR-NH2) | SFLLR-NH2 |
Thrombin Receptor Agonist (FLLRN) | FLLRN |
STAL-2 | SFLLRN-NH2 |
Scrambled TRAP Fragment | FSLLRN-NH2 |
SLLK, Control Peptide for TSP1 Inhibitor | SLLK-NH2 |
ω-Conotoxin GVIA | CKS(Hyp)GSSCS(Hyp)TSYNCCRSCN(Hyp)YTKRCY-NH2 |
Caloxin 1b1 | TAWSEVLHLLSRGGG |
Caloxin 2A1 | VSNSNWPSFPSSGGG |
Caloxin 3A1 | WSSTSSVSAPLEFGGGGSAK |
Conantokin G | GE(Gla)(Gla)LQ(Gla)NQ(Gla)LIR(Gla)KSN-NH2 |
Delta-Toxin (1-26), Staphylococcus aureus | MAQDIISTIGDLVKWIIDTVNKFTKK |
Tetanus Toxin (830-844) | QYIKANSKFIGITEL |
[Lys(Ac)40]-Ac-a-Tubulin (29-50)-WGK(Biotin); TubK40(Ac)-WGK, biotin-labeled | Ac-GIQPDGQMPSD-K(ac)-TIGGGDDSFNWG-K(biotin) |
B8R (20-27) | TSYKFESV |
CKS-17 (dimer), MN10021 | LQNRRGLDLLFLKEGGLC (dimer) |
CMV pp65 peptide | SVLGPISGHVLKAVF |
HSV-gB2 (498-505) | SSIEFARL |
Human Papillomavirus (HPV) E7 protein (49-57) | RAHYNIVTF |
Influenza A NP (366-374) Strain A/NT/60/68 | ASNENMDAM |
Influenza HA (307-319) | PKYVKQNTLKLAT |
Influenza Matrix Protein (62-70), MP (62-70) | GFVFTLTVPSER |
Influenza NP (147-155) | TYQRTRALV |
Influenza Virus Nucleoprotein (311-325) | QVYSLIRPNENPAHK |
IV9 (476-484), HIV-1 RT Epitope | ILKEPVHGV |
LCMV GP (61-80) | GLKGPDIYKGVYQFKSVEFD |
Lymphocytic Choreomeningitis Virus (LCMV) Glycoprotein 33 (33-41), LCMV GP1, gp 33 (33-41) | KAVYNFATC |
PA (224-233), Influenza | SSLENFRAYV |
Plasmodium falciparum Circumsporozoite Protein, (6NANP) PfCSP | NANPNANPNANPNANPNANPNANPC |
VSV-G Peptide | YTDIEMNRLGK |
(Des-His⁶)-ACTH (1-24) (human, bovine, rat) | SYSMEFRWGKPVGKKRRPVKVYP |
Acetyl-ACTH (3-24) (human, bovine, rat) | Ac-SMEHFRWGKPVGKKRRPVKVYP |
(Des-Glu⁵)-ACTH (1-24) (human, bovine, rat) | SYSMHFRWGKPVGKKRRPVKVYP |
Acetyl-ACTH (7-24) (human, bovine, rat) | Ac-FRWGKPVGKKRRPVKVYP |
ACTH (2-24) (human, bovine, rat) | YSMEHFRWGKPVGKKRRPVKVYP |
(Des-Ser3)-ACTH (1-24) (human, bovine, rat) | SYMEHFRWGKPVGKKRRPVKVYP |
Acetyl-ACTH (2-24) (human, bovine, rat) | Ac-YSMEHFRWGKPVGKKRRPVKVYP |
Endo-4a-Glu-ACTH (1-24) (human, bovine, rat) | SYSMEEHFRWGKPVGKKRRPVKVYP |
Acetyl-ACTH (4-24) (human, bovine, rat) | Ac-MEHFRWGKPVGKKRRPVKVYP |
ACTH (3-24) (human, bovine, rat) | SMEHFRWGKPVGKKRRPVKVYP |
ACTH (1-14) | SYSMEHFRWGKPVG |
ACTH (1-16), human | SYSMEHFRWGKPVGKK |
α-MSH (4-10), ACTH (4-10), human | MEHFRWG |
ACTH (11-24) | KPVGKKRRPVKVYP |
ACTH (22-39) | VYPNGAEDESAEAFPLEF |
ACTH (1-13), human | SYSMEHFRWGKPV |
ACTH (1-4) | SYSM |
ACTH (1-39) (mouse, rat) | SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF |
N-Acetyl-ACTH (1-17), human | Ac-SYSMEHFRWGKPVGKKR |
R-E-D-V | REDV |
Procollagen Type I (212-216) | KTTKS |
Collagen Type I α1 chain (502-516) | H-Gly-Phe-Hyp-Gly-Glu-Arg-Gly-Val-Glu-Gly-Pro-Hyp-Gly-Pro-Ala-NH₂ |
Ac-Pro-Gly-Pro (PGP) | Ac-PGP |
Annexin A1 (1-25) (dephosphorylated) (human) | Ac-AMVSEFLKQAWFIENEEQEYVQTVK |
Neural-Cadherin (76-85) amide (chicken) | LRAHAVDVNG-NH₂ |
Osteoblast-Adhesive Peptide | KRSR |
α₂β₁ Integrin Recognition Sequence | DGEA |
[Lys(Ac)12]-Histone H4 (1-25)-GSGSK(Biotin); H4K12(Ac), biotin-labeled | SGRGKGGKGLG-K(Ac)-GGAKRHRKVLRDNGSGS-K(Biotin) |
[Lys(Ac)16]-Histone H4 (1-25)-GSGSK(Biotin); H4K16(Ac), biotin-labeled | SGRGKGGKGLGKGGA-K(Ac)-RHRKVLRDNGSGS-K(Biotin) |
[Lys(Ac)20]-Histone H4 (1-25)-GSGSK(Biotin); H4K20(Ac), biotin-labeled | SGRGKGGKGLGKGGAKRHR-K(Ac)-VLRDNGSGS-K(Biotin) |
[Lys(Ac)5]-Histone H4 (1-25)-GSGSK(Biotin); H4K5(Ac), biotin-labeled | SGRG-K(Ac)-GGKGLGKGGAKRHRKVLRDNGSGS-K(Biotin) |
[Lys(Ac)8]-Histone H4 (1-25)-GSGSK(Biotin); H4K8(Ac), biotin-labeled | SGRGKGG-K(Ac)-GLGKGGAKRHRKVLRDNGSGS-K(Biotin) |
Histone H4 (1-25)-GSGSK(Biotin) | SGRGKGGKGLGKGGAKRHRKVLRDNGSGS-K(Biotin) |
[Lys(Ac)12/16]-Histone H4(1-25)-GSGSK(Biotin); H4K12/16(Ac), biotin-labeled | SGRGKGGKGLG-K(Ac)-GGA-K(Ac)-RHRKVLRDNGSGS-K(Biotin) |
Histone H4 (1-7), N-Terminal | SGRGKGG |
[Arg(Me2a)3]-Histone H4 (1-23)-GGK(Biotin) | SG-R(Me2a)-GKGGKGLGKGGAKRHRKVLRGG-K(Biotin) |
[Lys(Ac)12/16, Lys(Me3)20]-Histone H4 (1-25)-GSGSK(Biotin) | SGRGKGGKGLG-K(Ac)-GGA-K(Ac)-RHR-K(Me3)-VLRDNGSGS-K(Biotin) |
[Lys(Ac)5/8/12/16]-Histone H4 (1-25)-GSGSK | SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHRKVLRDNGSGSK |
[Lys(Me1)20]-Histone H4 (8-30)-WGK(Biotin); H4K20(Me1) (8-30), biotin-labeled | Ac-KGLGKGGAKRHR-K(Me1)-VLRDNIQGIT-WGK(biotin) |
Histone H4 (8-30)-WGK(Biotin) | Ac-KGLGKGGAKRHRKVLRDNIQGIT-WGK(biotin) |
[Lys(Me2)20]-Histone H4 (8-30)-WGK(Biotin); H4K20(Me2) (8-30), biotin-labeled | Ac-KGLGKGGAKRHR-K(Me2)-VLRDNIQGITWG-K(biotin) |
[Lys(Me3)20]-Histone H4 (8-30)-WGK(Biotin); H4K20(Me3) (8-30), biotin-labeled | Ac-KGLGKGGAKRHR-K(Me3)-VLRDNIQGITWG-K(biotin) |
Histone H4 (1-20), PRMT7 Substrate, M1 | SGRGKGGKGLGKGGAKRHRK-NH2 |
[Lys(Ac)5]-Histone H4 (1-20), H4K5(Ac) | SGRG-K(Ac)-GGKGLGKGGAKRHRK |
[Lys(Ac)8]-Histone H4 (1-20), H4K8(Ac) | SGRGKGG-K(Ac)-GLGKGGAKRHRK |
[Lys(Ac)12]-Histone H4 (1-20), H4K12(Ac) | SGRGKGGKGLG-K(Ac)-GGAKRHRK |
[Lys(Ac)16]-Histone H4 (1-20), H4K16(Ac) | SGRGKGGKGLGKGGA-K(Ac)-RHRK |
Histone H4 (1-21)-Lys(Biotin) | Ac-SGRGKGGKGLGKGGAKRHRKVGG-K(Biotin) |
Histone H4 (1-21), p300/CBP Substrate | SGRGKGGKGLGKGGAKRHRKV |
[Arg(Me1)3]-Histone H4(1-21)-GGK(Biotin), H4R3(Me1), biotin-labeled | Ac-SG-R(Me1)-GKGGKGLGKGGAKRHRKVGG-K(Biotin) |
[Arg(Me2a)3]-Histone H4(1-21)-GGK(Biotin), H4R3(Me2a), biotin-labeled | Ac-SG-R(Me2a)-GKGGKGLGKGGAKRHRKVGG-K(Biotin) |
[Arg(Me2s)3]-Histone H4 (1-21)-GGK(Biotin); H4R3(Me2s) (1-21), biotin-labeled | Ac-SG-R(me2s)-GKGGKGLGKGGAKRHRKV-GGK(biotin) |
AKT/PKB/Rac-Protein Kinase Substrate [ARKRERTYSFGHHA], Biotinylated | Biotin-ARKRERTYSFGHHA |
CDK5 Substrate | PKTPKKAKKL |
Histone deacetylase, HDAC substrate | Ac-RGK(Ac)-AMC |
C34, gp41 HIV Fragment | WMEWDREINNYTSLIHSLIEESQNQQEKNEQELL |
Gag Spacer Peptide P1 | HHHHHHIIKIIK |
Prostatic Acid Phosphatase (248-286), PAP (248-286) | GIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMY |
T20 | Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2 |
Integrin-Binding Site, GRGDNP | GRGDNP |
Laminin Pentapeptide | YIGSR |
GALA, Pore-Forming Peptide | WEAALAEALAEALAEHLAEALAEALEALAA |
Ryanodine receptor 1 (RyR1) (3614-3643); Calmodulin Binding Peptide (CaMBP) | KSKKAVWHKLLSKQRRRAVVACFRMTPLYN |
Crosstide [GRPRTSSFAEG] | GRPRTSSFAEG |
Autocamtide-2[KKALRRQETVDAL] | KKALRRQETVDAL |
Syntide-2[PLARTLSVAGLPGKK] | PLARTLSVAGLPGKK |
HATPPKKKRK | HATPPKKKRK |
CK1 Peptide Substrate [pS7] | KRRRAL-pS-VASLPGL |
Casein Kinase 2 (CK2) Substrate α-subunit | RRRDDDSDDD |
Glycogen Synthase 1-10, 5-FAM labeled | 5-FAM-PLSRTLSVSS-NH2 |
Insulin Receptor (1142-1153), pTyr(1146, 1150, 1151) | TRDI-pY-ETD-pY-pY-RK |
Insulin Receptor (1142-1153), pTyr1146 | TRDI-pY-ETDYYRK |
Insulin Receptor (1142-1153), pTyr1150 | TRDIYETD-pY-YRK |
Syk Kinase Peptide Substrate | KEDPDYEWPSAK-NH2 |
Syk Kinase Peptide Substrate, Biotin labeled | Biotin-KEDPDYEWPSAK-NH2 |
MBP, MAPK Substrate, Biotinylated | Biotin-APRTPGGRR |
MBP, MAPK Substrate, Biotinylated, Phosphorylated | Biotin-APR-pT-PGGRR |
Myosin Regulatory Light Chain MRCL3 (11-24) | KKRPQRATSNVFAM-NH2 |
pp60(v-SRC) Autophosphorylation Site, Phosphorylated | RRLIEDNE-pY-TARG |
CREBtide [KRREILSRRPSYR] | KRREILSRRPSYR |
CREBtide [KRREILSRRPSYR], Phosphorylated, C-term K | KRREILSRRPS-pY-RK |
Kemptide [LRRASLG] | LRRASLG |
[Ser25]-PKC (19-31), biotinylated | K(Biotin)-RFARKGSLRQKNV |
Neurogranin 28-43[AAKIQASFRGHMARKK], Biotinylated-LC | Biotin-LC-AAKIQASFRGHMARKK |
PKC (Protein Kinase C) Substrate | ERMRPRKRQGSVRRRV |
PKG Substrate [RKRSRAE], Glasstide | RKRSRAE |
P70 S6 Kinase Substrate | KKRNRTLTV |
S6 Kinase Substrate (229-239) | AKRRRLSSLRA |
S6 Kinase Substrate (229-239), Amide, Biotinalyted | Biotin-AKRRRLSSLRA-NH2 |
Srctide | GEEPLYWSFPAKKK-NH2 |
Srctide, biotinylated | Biotin-GEEPLYWSFPAKKK-NH2 |
Srctide, FAM labeled | 5-FAM-GEEPLYWSFPAKKK-NH2 |
LKBtide; LKB1/STK11 Substrate Peptide | LSNLYHQGKFLQTFCGSPLYRRR |
Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK], 5-TMR labeled | KVEKIGEGTYGVVYK |
Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG], Phosphorylated | RRLIEDAE-pY-AARG |
Luteinizing Hormone-Releasing Hormone (LH-RH), human | Pyr-HWSYGLRPG-NH2 |
Cetrorelix Acetate, Cetrotide | Ac-{d-A[3-(2-naphthyl)]}-[d-F(4-Cl)]-{d-A[3-(3-pyridyl)]}-SY-(d-Cit)-LRP-d-A-NH2?Acetate |
MAPS, Core, 8-Branch | K4K2KA-NH2 |
[Leu27]-Melan-A, MART 1 (26-35) | ELAGIGILTV |
Melan-A, MART 1 (26-35) | EAAGIGILTV |
Melan-A/MART-1 (27-35) | AAGIGILTV |
MUC1, mucin core | GVTSAPDTRPAPGSTA |
NDP-MSH, 5-TAMRA-labeled | 5-TMR-SYS-Nle-EHfRWGKPV-NH2 |
Adeno-Associated Virus Epitope 2 (AAV2) | VPQYGYLTL |
BDC2.5 mimotope 1040-31 | YVRPLWVRME |
Dby HY Peptide | NAGFNSNRANSSRSS |
Eα (52-68) | ASFEAQGALANIAVDKA |
Glutamic Acid Decarboxylase (GAD65) (524-543), p524-543 | SRLSKVAPVIKARMMEYGTT |
IL-8 Inhibitor | Ac-RRWWCR-NH2 |
LCMV (276-286), GP276 | SGVENPGGYCL |
LCMV gp33-41 | KAVYNFATM |
LLO190 | NEKYAQAYPNVS |
Mgp100 (25-33), mouse | EGSRNQDWL |
NY-ESO-1 (87-111) | LLEFYLAMPFATPMEAELARRSLAQ |
Uty HY Peptide (246-254), mouse | WMHHNMDLI |
Plasmepsin V FRET Substrate | Dabcyl-LNKRLLHETQ-EDANS |
Poly-γ-D-Glutamic Acid Construct | Ac-(γ-e)15-C-NH2 |
Humanin, HN | MAPRGFSCLLLLTSEIDLPVKRRA |
MOTS-c | H-MRWQEMGYIFYPRKLR-OH |
SHLP1 (Small humanin-like peptide 1) | H-MCHWAGGASNTGDARGDVFGKQAG-OH |
SHLP3 (Small humanin-like peptide 3) | H-MLGYNFSSFPCGTISIAPGFNFYRLYFIWVNGLAKVVW-OH |
SHLP4 (Small humanin-like peptide 4) | H-MLEVMFLVNRRGKICRVPFTFFNLSL-OH |
SHLP6 (Small humanin-like peptide 6) | H-MLDQDIPMVQPLLKVRLFND-OH |
MOG (35-55), mouse, rat | MEVGWYRSPFSRVVHLYRNGK |
MOG (35-55), human | MEVGWYRPPFSRVVHLYRNGK |
MOG (89-113), human | RFSDEGGFTCFFRDHSYQEEAAMEL |
MOG (92-106) | DEGGYTCFFRDHSYQ |
[Cit 2/8/17]-Histone H3 (1-21)-GGK(Biotin), amide | A-Cit-TKQTA-Cit-KSTGGKAP-Cit-KQLAGG-K(Biotin)-NH2 |
[Lys(Ac)4]-Histone H3 (1-21)-GGK(Biotin) | ART-K(Ac)-QTARKSTGGKAPRKQLAGG-K(biotin) |
[Lys(Me1)4]-Histone H3 (1-21), H3K4(Me1) | ART-K(Me1)-QTARKSTGGKAPRKQLA |
[Lys(Me2)4]-Histone H3 (1-21), H3K4(Me2) | ART-K(Me2)-QTARKSTGGKAPRKQLA |
[Lys(Me3)4]-Histone H3 (1-21), H3K4(Me3) | ART-K(Me3)-QTARKSTGGKAPRKQLA |
[Lys(Me3)4]-Histone H3 (1-21)-GGK(Biotin), H3K4(Me3), biotin labeled | ART-K(Me3)-QTARKSTGGKAPRKQLA-GGK(Biotin)-NH2 |
[Lys(Me1)4]-Histone H3 (1-21)-GGK(Biotin), H3K4(Me1), biotin-labeled | ART-K(Me1)-QTARKSTGGKAPRKQLA-GGK(Biotin) |
[Lys(Me2)4]-Histone H3 (1-21)-GGK(Biotin), H3K4(Me2), biotin-labeled | ART-K(Me2)-QTARKSTGGKAPRKQLA-GGK(Biotin) |
[Lys(Me3)4]-Histone H3 (1-21)-GGK(Biotin), H3K4(Me3), biotin-labeled | ART-K(Me3)-QTARKSTGGKAPRKQLA-GGK(Biotin) |
[Lys (Me3)4, Lys (Ac)9, pSer10]-Histone H3 (1-21) | ART-K(Me3)-QTAR-K(Ac)-pS-TGGKAPRKQLA |
[Arg(Me1)8]-Histone H3 (1-21)-K(Biotin), H3R8(Me1), biotin labeled | ARTKQTA-R(Me1)-KSTGGKAPRKQLA-K(Biotin)-NH2 |
[Arg(Me2a)8]-Histone H3(1-21)-K(Biotin), H3R8(Me2a), biotin-labeled | ARTKQTA-R(Me2a)-KSTGGKAPRKQLA-K(Biotin)-NH2 |
[Arg(Me2s)8]-Histone H3 (1-21), biotin-labeled | ARTKQTA-R(Me2s)-KSTGGKAPRKQLA-K(Biotin) |
[Lys(Ac)9]-Histone H3 (1-21), H3K9(Ac) | ARTKQTAR-K(Ac)-STGGKAPRKQLA |
[Lys(Ac)9]-Histone H3 (1-21)-NH2, H3K9(Ac), biotin-labeled, amide | ARTKQTAR-K(Ac)-STGGKAPRKQLA-GGK(Biotin)-NH2 |
[Lys(Ac)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Ac), biotin-labeled | ARTKQTAR-K(Ac)-STGGKAPRKQLA-GGK(Biotin) |
[Lys(Ac)9/14]-Histone H3 (1-21)-GGK(Biotin), H3K9/14(Ac), biotin-labeled | ARTKQTAR-K(Ac)-STGG-K(Ac)-APRKQLA-GGK(Biotin) |
[Lys(Me1)9]-Histone H3 (1-21), biotin-labeled | ARTKQTAR-K(Me1)-STGGKAPRKQLA-K(Biotin) |
[Lys(Me1)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Me1), biotin-labeled | ARTKQTAR-K(Me1)-STGGKAPRKQLA-GGK(Biotin) |
[Lys(Me1)9]-Histone H3 (1-21)-GGK(Biotin); H3K9(Me1), biotin-labeled, amide | ARTKQTAR-K(Me1)-STGGKAPRKQLA-GGK(Biotin)-NH2 |
[Lys(Me2)9]-Histone H3 (1-21) | ARTKQTAR-K(Me2)-STGGKAPRKQLA |
[Lys(Me2)9]-Histone H3 (1-21)-K(Biotin), H3K9(Me2), biotin labeled | ARTKQTAR-K(Me2)-STGGKAPRKQLA-K(Biotin) |
[Lys(Me2)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Me2), biotin-labeled | ARTKQTAR-K(Me2)-STGGKAPRKQLA-GGK(Biotin) |
[Lys(Me2)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Me2), biotin-labeled, amide | ARTKQTAR-K(Me2)-STGGKAPRKQLA-GGK(Biotin)-NH2 |
[Lys(Me3)9]-Histone H3 (1-21), H3K9(Me3) | ARTKQTAR-K(Me3)-STGGKAPRKQLA |
[Lys(Me3)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Me3), biotin-labeled | ARTKQTAR-K(Me3)-STGGKAPRKQLA-GGK(Biotin) |
[Lys(Me3)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Me3), biotin-labeled, amide | ARTKQTAR-K(Me3)-STGGKAPRKQLAGG-K(Biotin)-NH2 |
[pSer10]-Histone H3 (1-21)-GGK(Biotin); H3pS10, biotin-labeled | ARTKQTARK-pS-TGGKAPRKQLA-GGK(Biotin)-NH2 |
[pSer10), Lys(Ac)14]-Histone H3 (1-21)-GGK(Biotin), biotin-labeled | ARTKQTARK-pS-TGG-K(Ac)-APRKQLAGGK(Biotin) |
[pThr11]-Histone H3(1-21)-GGK(Biotin), H3pT11, biotin-labeled | ARTKQTARKS-pT-GGKAPRKQLAGG-K(Biotin)-NH2 |
[Lys(Ac)14]-Histone H3 (1-21)-GGK(Biotin), H3K14(Ac), biotin-labeled | ARTKQTARKSTGG-K(Ac)-APRKQLA-GGK(Biotin) |
[Arg(Me1)17]-Histone H3 (1-21)-GGK(Biotin), H3R17(Me1), biotin-labeled | ARTKQTARKSTGGKAP-R(Me1)-KQLA-GGK(Biotin)-NH2 |
[Cit17]-Histone H3 (1-21)-GGK(Biotin) | ARTKQTARKSTGGKAP-Cit-KQLAGG-K(Biotin) |
[Lys(Ac)18]-Histone 3 (1-21)-GGK(Biotin); H3K18(Ac), biotin-labeled | ARTKQTARKSTGGKAPR-K(Ac)-QLA-GGK(Biotin)-NH2 |
[Lys(Me1)18]-Histone H3 (1-21)-GGK(Biotin), H3K18(Me1), biotin-labeled | ARTKQTARKSTGGKAPR-K(Me1)-QLA-GGK(Biotin)-NH2 |
[Lys(Me2)18]-Histone H3 (1-21)-GGK(Biotin), H3K18(Me2), biotin-labeled | ARTKQTARKSTGGKAPR-K(Me2)-QLA-GGK(Biotin)-NH2 |
[Lys(Ac)9]-Histone H3 (1-24), H3K9(Ac) | ARTKQTAR-K(Ac)-STGGKAPRKQLATKA |
[Lys(Ac)14/18/23]-Histone H3 (1-24)-GGK(Biotin) | ARTKQTARKSTGG-K(Ac)-APR-K(Ac)-QLAT-K(Ac)-AGG-K(Biotin) |
Histone H3 (1-25), amide | ARTKQTARKSTGGKAPRKQLATKAA-NH2 |
[Lys(Me3)4]-Histone H3 (1-25); H3K4(Me3) | ART-K(Me3)-QTARKSTGGKAPRKQLATKAA-NH2 |
[Lys(Ac)14/18/23/27]-Histone H3 (1-30)-GGK(Biotin) | ARTKQTARKSTGG-K(Ac)-APR-K(Ac)-QLAT-K(Ac)-AAR-K(Ac)-SAPGG-K(Biotin) |
Histone H3(1-35) | ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGV |
Histone H3 (1-50)-GGK(Biotin), biotin-labeled | ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREGG-K(Biotin) |
[Lys(Me1)9]-Histone H3 (3-17), H3K9(Me1) | TKQTAR-K(Me1)-STGGKAPR |
[Lys(Me2)9]-Histone H3 (3-17), H3K9(Me2) | TKQTAR-K(Me2)-STGGKAPR |
[Lys(Me3)9]-Histone H3 (3-17), H3K9(Me3) | TKQTAR-K(Me3)-STGGKAPR |
Histone H3 (5-23) | QTARKSTGGKAPRKQLASK |
[Lys(Ac)14]-Histone H3 (9-19), H3K14(Ac) | KSTGG-K(Ac)-APRKQ |
[Arg(Me2a)26]-Histone H3 (15-36)-GGK(Biotin), H3R26(Me2a), biotin labeled | APRKQLATKAA-R(Me2a)-KSAPATGGVKGG-K(Biotin) |
[Lys(Me2)36]-Histone H3 (21-44)-GK(Biotin), H3K36(Me2), biotin-labeled | ATKAARKSAPATGGV-K(Me2)-KPHRYRPG-GK(Biotin) |
[Lys(Me3)36]-Histone H3 (21-44)-GK(Biotin), H3K36(Me3), biotin-labeled | ATKAARKSAPATGGV-K(Me3)-KPHRYRPG-GK(Biotin) |
Histone H3 (21-44) | ATKAARKSAPATGGVKKPHRYRPG |
Histone H3 (21-44)-GK(Biotin), biotin-labeled | ATKAARKSAPATGGVKKPHRYRPG-GK(Biotin) |
Histone H3 (21-44)-GK(Biotin), biotin-labeled, amide | ATKAARKSAPSTGGVKKPHRYRPG-GK(Biotin)-NH2 |
[Lys(Ac)27]-Histone 3 (21-44)-GK(Biotin); H3K27(Ac), biotin-labeled | ATKAAR-K(Ac)-SAPSTGGVKKPHRYRPG-GK(Biotin)-NH2 |
[Lys(Me1)23]-Histone H3 (21-44)-GK(Biotin); H3K23(Me1), biotin-labeled | AT-K(Me1)-AARKSAPSTGGVKKPHRYRPG-GK(Biotin)-NH2 |
[Lys(Ac)27]-Histone H3 (21-43)-GGK(Biotin), H3K27(Ac), biotin-labeled | ATKAAR-K(Ac)-SAPATGGVKKPHRYRPGG-K(Biotin) |
[Lys(Me1)27]-Histone H3 (21-44)-GK(Biotin), H3K27(Me1), biotin-labeled | ATKAAR-K(Me1)-SAPATGGVKKPHRYRPG-GK(Biotin) |
[Lys(Me2)27]-Histone H3 (21-44)-GK(Biotin), H3K27(Me2), biotin-labeled | ATKAAR-K(Me2)-SAPATGGVKKPHRYRPG-GK(Biotin) |
[Lys(Me3)27]-Histone H3 (21-44)-GK(Biotin), H3K27(Me3), biotin-labeled | ATKAAR-K(Me3)-SAPATGGVKKPHRYRPG-GK(Biotin) |
[Lys(Ac)36]-Histone H3 (21-44)-GK(Biotin), H3K36(Ac), biotin-labeled | ATKAARKSAPATGGV-K(Ac)-KPHRYRPGG-K(Biotin) |
[pSer28]-Histone H3 (21-44)-GK (Biotin), biotin-labeled | ATKAARK-pS-APATGGVKKPHRYRPGG-K(Biotin) |
[Cit26]-Histone H3 (21-44)-GGK(Biotin) | ATKAA-Cit-KSAPATGGVKKPHRYRPGGG-K(Biotin) |
[Lys(Ac)23]-Histone H3 (21-44)-GK(Biotin); H3K23(Ac), biotin-labeled | AT-K(Ac)-AARKSAPATGGVKKPHRYRPGG-K(Biotin) |
[Lys(Me1)36]-Histone H3 (21-44)-GK(Biotin), H3K36(Me1), biotin-labeled | ATKAARKSAPATGGV-K(Me1)-KPHRYRPG-GK(Biotin) |
Histone H3 (23-34) | KAARKSAPATGG |
[Lys(Ac)27]-Histone H3 (23-34), H3K27(Ac) | KAAR-K(Ac)-SAPATGG |
[Lys(Me1)27]-Histone H3 (23-34), H3K27(Me1) | KAAR-K(Me1)-SAPATGG |
[Lys(Me2)27]-Histone H3 (23-34), H3K27(Me2) | KAAR-K(Me2)-SAPATGG |
[Lys(Me3)27]-Histone H3 (23-34), H3K27(Me3) | KAAR-K(Me3)-SAPATGG |
[Lys(Me3)27-Histone H3 (23-34)-GGK(Biotin) | KAAR-K(Me3)-SAPATGGGG-K(Biotin) |
[Lys(Me1)36]-Histone H3 (26-46)-K(Biotin), H3K36(Me1), Schizosaccharomyces octosporus | RKAAPATGGV-K(Me1)-KPHRYRPGTV-K(BIOTIN) |
[Lys(Me2)36]-Histone H3 (26-46), H3K36(Me2) | RKAAPATGGV-K(Me2)-KPHRYRPGTV-K(BIOTIN) |
[Lys(Me1)36]-Histone H3 (31-41), H3K36(Me1) | STGGV-K(Me1)-KPHRY |
[Lys(Me2)36]-Histone H3 (31-41), H3K36(Me2) | STGGV-K(Me2)-KPHRY |
[Lys(Me3)36]-Histone H3 (31-41), H3K36(Me3) | STGGV-K(Me3)-KPHRY |
[Lys(Ac)56]-Histone H3 (44-63) | GTVALREIRRYQ-K(Ac)-STELLIR |
Histone H3 (69-89)-K(Biotin) | RLVREIAQDFKTDLRFQSSAV-K(Biotin) |
[Lys(Me2)79]-Histone H3 (69-89)-K(Biotin), H3K79(Me2), biotin-labeled | RLVREIAQDF-K(Me2)-TDLRFQSSAV-K(Biotin) |
[Lys(Me1)79]-Histone H3 (69-89)-K(Biotin), H3K79(Me1), biotin labeled | RLVREIAQDF-K(Me1)-TDLRFQSSAV-K(Biotin) |
[Lys(Me3)79]-Histone H3 (69-89)-K(Biotin), H3K79(Me3), biotin labeled | RLVREIAQDF-K(Me3)-TDLRFQSSAV-K(biotin) |
Histone H3 (116-136), C116-136 | KRVTIMPKDIQLARRIRGERA |
[Lys(Me1)9]-Histone H3 (1-21), H3K9(Me1) | ARTKQTAR-K(Me1)-STGGKAPRKQLA |
[Lys(Me1)20]-Histone H4 (1-23)-GGK(Biotin), H4K20(Me1), biotin-labeled | SGRGKGGKGLGKGGAKRHR-K(Me1)-VLR-GGK(Biotin)-NH2 |
[Lys(Me3)20]-Histone H4 (1-23)-GGK(Biotin), H4K20(Me3), biotin-labeled | SGRGKGGKGLGKGGAKRHR-K(Me3)-VLR-GGK(Biotin)-NH2 |
[Lys(Me2)20]-Histone H4 (1-23)-GGK(Biotin), H4K20(Me2), biotin-labeled | SGRGKGGKGLGKGGAKRHR-K(Me2)-VLR-GGK(Biotin)-NH2 |
[Lys(Ac)5]-Histone H4 (1-21)-GGK(Biotin), H4K5(Ac), biotin-labeled | Ac-SGRG-K(Ac)-GGKGLGKGGAKRHRKVGG-K(Biotin) |
[Lys(Ac)16]-Histone H4 (1-21)-GGK(Biotin), H4K16(Ac), biotin-labeled | Ac-SGRGKGGKGLGKGGA-K(Ac)-RHRKVGG-K(Biotin) |
[Lys(Ac)8]-Histone H4 (1-21)-GGK(Biotin), H4K8(Ac), biotin-labeled | Ac-SGRGKGG-K(Ac)-GLGKGGAKRHRKV-GGK(Biotin) |
Histone H4 (1-23)-GSGSK, C-terminal biotin-labeled | SGRGKGGKGLGKGGAKRHRKVLRGSGS-K(Biotin) |
[Lys(Ac)12]-Histone H4 (1-21)-GGK(Biotin), H4K12(Ac), biotin-labeled | Ac-SGRGKGGKGLG-K(Ac)-GGAKRHRKVGG-K(Biotin) |
Histone H4 (8-25)-WC, amide | KGLGKGGAKRHRKVLRDNWC-NH2 |
[Lys(Ac)5/8/12/16]-Histone H4 (1-21)-GGK(Biotin), H4K5/8/12/16(Ac), biotin-labeled | SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHRKVGG-K(Biotin) |
Histone H4 (1-23)-GGK(Biotin), biotin labeled, amide | SGRGKGGKGLGKGGAKRHRKVLRGG-K(Biotin)-NH2 |
[Lys(Me1)12]-Histone H4(1-21)-GGK(Biotin), H4K12(Me1), biotin-labeled | Ac-SGRGKGGKGLG-K(Me1)-GGAKRHRKVGG-K(Biotin) |
[Lys(Me3)12]-Histone H4(1-21)-GGK(Biotin), H4K12(Me3), biotin-labeled | Ac-SGRGKGGKGLG-K(Me3)-GGAKRHRKVGG-K(Biotin) |
[Cit3]-Histone H4 (1-23)-GGK(Biotin) | SG-Cit-GKGGKGLGKGGAKRHRKVLRGG-K(Biotin) |
[Arg(Me1)3]-Histone H4 (1-23)-GGK(Biotin) | SG-R(Me1)-GKGGKGLGKGGAKRHRKVLRGG-K(Biotin) |
[Arg(Me2s)3]-Histone H4 (1-23)-GGK(Biotin) | SG-R(Me2s)-GKGGKGLGKGGAKRHRKVLRGG-K(Biotin) |
[Lys(Ac) 5/8/12/16]-Histone H4 (1-25)-GSGSK(Biotin) | SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHRKVLRDNGSGS-K(Biotin) |
Elastase/Trypsin Substrate, fluorogenic | (Z-AR)2Rh110•HCl |
Enterokinase Substrate | GDDDDK-βNA |
gp91 ds-tat | YGRKKRRQRRRCSTRIRRQL-NH2 |
gp91 ds-tat Peptide 2 | RKKRRQRRRCSTRIRRQL-NH2 |
gp91 ds-tat Peptide 2; sgp91 ds-tat Peptide 2, scrambled | RKKRRQRRRCLRITRQSR-NH2 |
gp91 ds-tat, FAM labeled | 5-FAM-YGRKKRRQRRRCSTRIRRQL-NH2 |
gp91 ds-tat; sgp91 ds-tat, scrambled | YGRKKRRQRRRCLRITRQSR-NH2 |
IRAK-1 (360-380); IRAK-4 Peptide Substrate | KKARFSRFAGSSPSQSSMVAR |
Mucin 10 (153-165), EA2 | PTTDSTTPAPTTK |
O-linked GlcNAc transferase (OGT) Substrate | KKKYPGGSTPVSSANMM |
Proteases Substrate, Fluorogenic | (Z-R)2Rh110 • 2HCl |
S2238, Thrombin Substrate | f-Pip-R-pNA |
α1(I) Collagen (614-639), Type I Collagen α1(I) C-Telopeptide, human | SAGFDFSFLPQPPQEKAHDGGRYYRA |
Laminin α1 (2110-2127), amide, mouse | CSRARKQAASIKVAVSADR-NH2 |
[Glu1]-Fibrinopeptide B | Glufib |
[Glu3]-RGES, Control for RGD Peptides | RGES |
GRGDS, amide | GRGDS-NH2 |
GRGDS, LC-biotin labeled | Biotin-LC-GRGDS |
Integrin Binding Peptide | Ac-GCGYGRGDSPG-NH2 |
390 MMP FRET Substrate I | Mca-PLGL-Dpa-AR-NH2 |
2837b, Hemoglobin Fragment, Plasmepsin II (PM II) substrate, EDANS/ DABCYL | EDANS-CO-CH2-CH2-CO-ALERMFLSFP-Dap(DABCYL)OH |
390 MMP FRET Substrate II | Mca-PLGL-Dpa-AR |
390 MMP FRET Substrate IV | Mca-P-Cha-G-Nva-HA-Dpa-NH2 |
390 MMP FRET Substrate V | Mca-PLGLEEA-Dpa-NH2 |
490 MMP FRET Substrate III | DABCYL-RPLALWRS-EDANS |
5-FAM MMP FRET Peptide Fluorescence Standard I | 5-FAM-PL |
5-FAM-PMDM6 (PMDM6-F) | 5-FAM-(β-A)-(β-A)-FM-Aib-pY-(6-Cl-DL-Trp)-E-Ac3c-LN-NH2 |
Abltide, TAMRA-labeled | 5-TAMRA-KKGEAIYAAPFA-NH2 |
Cls Substrate, C2 (Abz/Dnp) | 2Abz-SLGRKIQIK(Dnp)-NH2 |
CREBtide [KRREILSRRPSYR], 5-FAM labeled | 5-FAM-KRREILSRRPSYR |
Crosstide [GRPRTSSFAEG], 5-FAM labeled | 5-FAM-GRPRTSSFAEG |
CSK tide, FAM labeled | 5-FAM-KKKKEEIYFFFG-NH2 |
EGF Receptor Substrate 2 [DADE-pY-LIPQQG], 5-FAM labeled | 5-FAM-DADE-pY-LIPQQG |
HCV Protease FRET Substrate (RET S1) | Ac-DE-D(Edans)-EE-Abu-ψ-[COO]-AS-K(Dabcyl)-NH2 |
Histone H1-derived Peptide, FAM-labeled | 5-FAM-GGGPATPKKAKKL |
Histone H3 (1-21), K4 methylated, FAM labeled | ART-K(Me)-QTARKSTGGKAPRKQLAGG-K(FAM)-NH2 |
HIV Protease FRET Substrate I | DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS |
Kemptide [LRRASLG], 5-FAM labeled | 5-FAM-LRRASLG |
MMP Colorimetric Substrate I | Ac-PLG-SCH[CH2CH(CH3)2]-CO-LG-OC2H5 |
NFF-3 | Mca-RPKPVE-Nva-WR-K(Dnp)-NH2 |
p53 (17-26), FITC labeled | FITC-LC-ETFSDLWKLL-NH2 |
SAM PEP 1, FAM labeled; AMPK substrate peptide, FAM labeled | 5-FAM-HMRSAMSGLHLVKRR |
Substance P, FAM-labeled | FAM-RPKPQQFFGLM-NH2 |
TNO211 | DABCYL-(γ-Abu)-PQGL-E(EDANS)AK-NH2 |
Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK], 5-TMR labeled | 5-TMR-KVEKIGEGTYGVVYK |
WAAG-3R, Aggrecanase (ADAM-TS-4) FRET Substrate | Abz-TEGEARGSVI-Dpa-KK-NH2 |
Galanin, human | GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS |
(Leu15)-Gastrin-1, human | Pyr-GPWLEEEEEAYGWLDF-NH2 |
Big Gastrin-1, human | Pyr-LGPQGPPHLVADPSKKQGPWLEEEEEAYGWMDF-NH2 |
Biotin-Gastrin (1-17) | Biotin-EGPWLEEEEEAYGWMDF-NH2 |
Gastrin Releasing Peptide, human | VPLPAGGGTVLTKMYPRGNHWAVGHLM-NH2 |
Gastrin-1, human | Pyr-GPWLEEEEEAYGWMDF-NH2 |
Gastrin-1, rat | Pyr-RPPMEEEEEAYGWMDF-NH2 |
Leptin (93-105), human | NVIQISNDLENLR |
[Des-octanoyl]-Ghrelin, human | GSSFLSPEHQRVQQRKESKKPPAKLQPR |
[Des-octanoyl]-Ghrelin, rat, mouse | GSSFLSPEHQKAQQRKESKKPPAKLQPR |
Biotin-Ghrelin, human | Biotin-GS-S(n-octanoyl)-FLSPEHQRVQQRKESKKPPAKLQPR |
Ghrelin, human | GS-S(n-octanoyl)-FLSPEHQRVQQRKESKKPPAKLQPR |
Ghrelin, rat, mouse | GS-S(n-octanoyl)-FLSPEHQKAQQRKESKKPPAKLQPR |
α-Gliadin (31-43) | LGQQQPFPPQQPY |
α9-Gliadin (57-68) | QLQPFPQPQLPY |
α-Mating Factor Pheromone, yeast | WHWLQLKPGQPMY |
Adrenomedullin (22-52), human | TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 |
[Leu31, Pro34]-Neuropeptide Y, human, rat | YPSKPDNPGEDAPAEDMARYYSALRHYINLLTRPRY-NH2 |
Neuropeptide Y, human, rat | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 |
Oxytocin | CYIQNCPLG-NH2 (Disulfide bridge: 1-6) |
Biotin-PACAP (1-38), amide, human, ovine, rat | Biotin-HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
PACAP (1-27), amide, human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2 |
PACAP (1-38), amide, human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
PACAP (1-38)-Lys(Biotin), amide, human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNKK(Biotin)-NH2 |
PACAP (6-38), amide, human, ovine, rat | FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
Secretin, rat | HSDGTFTSELSRLQDSARLQRLLQGLV-NH2 |
[Succinyl-Asp6, NMePhe8]-Substance P (6-11), Senktide | Suc-DF-(NMeF)-GLM-NH2 |
Substance P | RPKPQQFFGLM-NH2 |
BMP-2 Knuckle Epitope (73-92) | KIPKASSVPTELSAISTLYL |
EGF Receptor Substrate 2 [DADE-pY-LIPQQG], Biotinylated | Biotin-DADE-pY-LIPQQG |
EGFR Protein Tyrosine Kinase Substrate | ADEYLIPQQ |
Growth Hormone Releasing Factor, GRF (1-29), amide, human | YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 |
Hepatitis Virus C NS3 Protease Inhibitor 2 | Ac-DE-Dif-E-Cha-C |
PEP1 | SGSWLRDVWDWICTVLTDFKTWLQSKLDYKD-NH2 |
Histone H1-derived Peptide | GGGPATPKKAKKL |
Histone H2A (1-20) | SGRGKQGGKARAKAKTRSSR |
Histone H2A (1-20)-GGK(Biotin); biotin-labeled | SGRGKQGGKARAKAKTRSSRGG-K(Biotin) |
Histone H2A (1-22)-GK(Biotin) | SGRGKQGGKARAKAKSRSSRAG-GK(Biotin)-NH2 |
Histone H2B (21-41), biotin labeled | AQKKDGKKRKRSRKESYSIYVGG-K(Biotin) |
Histone H3 (1-8) | ARTKQTAR |
Histone H3 (73-83) | EIAQDFKTDLR |
[Lys(Me3)79]-Histone H3(73-83), H3K79(Me3) | EIAQDF-K(Me3)-TDLR |
[Lys(Ac)79]-Histone H3 (69-89), H3K79(Ac), biotin-labeled | RLVREIAQDF-K(Ac)-TDLRFQSSAV-K(biotin) |
[Lys(Me1)27/36]-Histone H3 (21-44)-GK(Biotin), H3K27(Me1)K36(Me1) | ATKAAR-K(Me1)-SAPATGGV-K(Me1)-KPHRYRPG-GK(Biotin) |
[Lys(Me2)27, Lys(Me1)36]-Histone H3 (21-44)-GK(Biotin), H3K27(Me2)K36(Me1), biotin-labeled | ATKAAR-K(Me2)-SAPATGGV-K(Me1)-KPHRYRPGG-K(Biotin) |
[Lys(Me1)4]-Histone H3 (1-10), H3K4(Me1) | ART-K(Me1)-QTARKS |
[Lys(Me2)4]-Histone H3 (1-10), H3K4(Me2) | ART-K(Me2)-QTARKS |
[Lys(Me3)4]-Histone H3 (1-10), H3K4(Me3) | ART-K(Me3)-QTARKS |
[Lys(Ac)14]-Histone H3 (1-19),H3K14(Ac) | ARTKQTARKSTGG-K(Ac)-APRKQ |
Histone H3 (1-20), N-Terminal | ARTKQTARKSTGGKAPRKQL |
[Lys(Ac)9]-Histone H3 (1-20), H3K9(Ac) | ARTKQTAR-K(Ac)-STGGKAPRKQL |
Histone H3 (1-21), Biotinylated | ARTKQTARKSTGGKAPRKQLA-GG-K(BIOTIN)-NH2 |
Histone H3 (1-21), FAM labeled | ARTKQTARKSTGGKAPRKQLAGG-K(FAM)-NH2 |
Histone H3 (1-21), N-Terminal | ARTKQTARKSTGGKAPRKQLA |
Cholecystokinin (26-33), CCK8 | DYMGWMDF-NH2 |
Angiotensin I, human, 13C and 15N-labeled | DRVY-I*-HPFHL [I*=I(U13C6,15N)] |
Angiotensin I, human, 13C and 15N labeled | DR-V*-Y-I*-HPFHL [Val*=Val(U-13C5,15N); Ile*=Ile(U-13C6,15N)] |
Angiotensin II, human, 13C and 15N-labeled | DRVY-I*-HPF [I*=I(U13C6,15N)] |
beta-Amyloid (1-38), 13C-Phe & Ile, Human | DAEFRHDSGYEVHHQKLV - *F - *F - AEDVGSNKGA-*I-*I-GLMVGG *F=Phe(U - 13C9), *I=Ile(U-13C6) |
beta-Amyloid (1-40), 13C,15N-labeled at Arg & Lys, Human | DAEF - R* - HDSGYEVHHQ-K*-LVFFAEDVGSN-K*-GAIIGLMVGGVV [R*=R(U-13C6, U-15N4) & K*=K(U-13C6, U-15N2)] |
beta-Amyloid (1-42), 13C, 15N-labeled at Arg & Lys, Human | DAEF-R*-HDSGYEVHHQ-K*-LVFFAEDVGSN-K*-GAIIGLMVGGVVIA [R*=R(U-13C6, U-15N4) & K*=K(U-13C6, U-15N2)] |
BSA (347-359), Isotopic labeled, Mass Spec Standard | DAF-L*-GSF-L*-YEYSR [L*=L(U13C6, 15N)] |
Biotin-Corticotropin Releasing Factor, Biotin - CRF, human, rat | Biotin-SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII-NH2 |
Corticotropin Releasing Factor, CRF, human, rat | SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII-NH2 |
Corticotropin Releasing Factor, CRF, ovine | SQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA-NH2 |
(Biotin-LC)-SARS-CoV-2 Spike RBM (receptor binding motif), 438-458 | Biotin-LC-SNNLDSKVGGNYNYLYRLFRK |
Spike glycoprotein from SARS-CoV-2 | Spike glycoprotein from SARS-CoV-2 |
DX 600, ACE2 Inhibitor | Ac-GDYSHCSPLRYYPWWKCTYPDPEGGG-NH2 |
SARS-CoV-2 Spike RBD (receptor binding domain), 319-335 | RVQPTESIVRFPNITNL |
SARS - CoV - 2 Spike RBD (receptor binding domain), 319-335-Lys(Biotin-LC) | RVQPTESIVRFPNITNL-K(Biotin-LC)-NH2 |
SARS-CoV-2 Spike RBD (receptor binding domain), 336-347 | CPFGEVFNATRF |
SARS - CoV - 2 Spike RBD (receptor binding domain), 336-347-Lys(Biotin-LC) | CPFGEVFNATRF-K(Biotin-LC)-NH2 |
SARS-CoV-2 Spike RBD (receptor binding domain), 348-357 | ASVYAWNRKR |
SARS - CoV - 2 Spike RBD (receptor binding domain), 348-357-Lys(Biotin-LC) | ASVYAWNRKR-K(Biotin-LC)-NH2 |
SARS-CoV-2 Spike RBD (receptor binding domain), 352-365 | AWNRKRISNCVADY |
SARS - CoV - 2 Spike RBD (receptor binding domain), 352-365-Lys(Biotin-LC) | AWNRKRISNCVADY-K(Biotin-LC)-NH2 |
SARS-CoV-2 Spike RBD (receptor binding domain), 371-394 | SASFSTFKCYGVSPTKLNDLCFTN |
SARS-CoV-2 Spike RBD (receptor binding domain), 371-394-Lys(Biotin-LC) | SASFSTFKCYGVSPTKLNDLCFTN-K(Biotin-LC)-NH2 |
SARS-CoV-2 Spike RBD (receptor binding domain), 395-430 | VYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFT |
SARS-CoV-2 Spike RBD (receptor binding domain), 395-430-Lys(Biotin-LC) | VYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFT-K(Biotin-LC)-NH2 |
SARS-CoV-2 Spike RBD (receptor binding domain), 513-520 | LSFELLHA |
SARS-CoV-2 Spike RBD (receptor binding domain), 513-520-Lys(Biotin-LC) | LSFELLHA-K(Biotin-LC)-NH2 |
SARS-CoV-2 Spike RBD (receptor binding domain), 523-541 | TVCGPKKSTNLVKNKCVNF |
SARS-CoV-2 Spike RBD (receptor binding domain), 523-541-Lys(Biotin-LC) | TVCGPKKSTNLVKNKCVNF-K(Biotin-LC)-NH2 |
SARS-CoV-2 Spike RBM (receptor binding motif), 438-458 | SNNLDSKVGGNYNYLYRLFRK |
SARS-CoV-2 Spike RBM (receptor binding motif), 450-473 | NYLYRLFRKSNLKPFERDISTEIY |
SARS-CoV-2 Spike RBM (receptor binding motif), 450-473-Lys(Biotin-LC) | NYLYRLFRKSNLKPFERDISTEIY-K(Biotin-LC)-NH2 |
SARS-CoV-2 Spike RBM (receptor binding motif), 480-496 | CNGVEGFNCYFPLQSYG |
SARS - CoV - 2 Spike RBM (receptor binding motif), 480-496-Lys(Biotin-LC) | CNGVEGFNCYFPLQSYG-K(Biotin-LC)-NH2 |
SARS-CoV-2 Spike RBM (receptor binding motif), 500-509 | TNGVGYQPYR |
SARS-CoV-2 Spike RBM (receptor binding motif), 500-509-Lys(Biotin-LC) | TNGVGYQPYR-K(Biotin-LC)-NH2 |
Cyclo (-GRGDSP) | GRGDSP, N to C cyclized |
Cyclo (-RADfK-), RGD negative control | Cyclo(-RADfK-) |
Cyclo (-RGDyK) | Cyclo(-RGDyK) |
Cyclo (RGDfC), avb3 Integrin Binding Cyclic RGD Peptide | Cyclo(-RGDfC) |
Cyclo-[GRGESP] | Cyclo-[GRGESP] |
Cyclo[-RGDy-K(5-FAM)] | Cyclo[-RGDy-K(5-FAM)] |
Aminopeptidase N Ligand (CD13), NGR peptide | CNGRCG (Disulfide bridge: 1-5) |
hBD-1, β-Defensin-1, human | DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK (Disulfide bridge: 5-34, 12-27, 17-35) |
Charybdotoxin | Pyr-FTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS (Disulfide bridge: 7-28, 13-33 and 17-35) |
Chlorotoxin (Cltx) | MCMPCFTTDHQMARKCDDCCGGKGRGKCYGPQCLCR-NH2 (Disulfide bridge: 2-19,5-28,16-33,20-35) |
hBD-3, β-Defensin-3, human | GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK (Disulfide bridge: 11-40, 18-33, 23-41) |
HNP-1, Defensin Human Neutrophil Peptide-1 | ACYCRIPACIAGERRYGTCIYQGRLWAFCC (Disulfide bridge: 2-30, 4-19, 9-29) |
HNP-2, Defensin Human Neutrophil Peptide-2 | CYCRIPACIAGERRYGTCIYQGRLWAFCC (Disulfide bridge: 1-29, 3-18, 8-28) |
Iberiotoxin (IbTX) | Pyr-FTDVDCSVSKECWSVCKDLFGVDRGKCMGKKCRCYQ(Disulfide bridge: C7-C28,C13-C33,C17-C35) |
Orexin A, bovine, human, mouse, rat | Pyr-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2 (Disulfide bridge: 6-12 and 7-14) |
RGD-4C | ACDCRGDCFCG (Disulfide bridge: 2-10 and 4-8) |
Somatostatin 14, human, rat, mouse, pig, chicken, frog | AGCKNFFWKTFTSC (Disulfide bridge: 3-14) |
Somatostatin 28, human, sheep, cow, rat, mouse, pig | SANSNPAMAPRERKAGCKNFFWKTFTSC (Disulfide bridge: 17-28) |
MCC (88-103) | ANERADLIAYLKQATK |
PCC (88-104) | KAERADLIAYLKQATAK |
CHRG01; Human β-Defensin 3 (hBD3) Derivative | KSSTRGRKSSRRKK |
Deltorphin A | YmFHLMD-NH2 |
Deltorphin B | YaFEVVG-NH2 |
[FAM-Trp31]-GLP-1 (7-36), Fluorescent label at Trp31 | HAEGTFTSDVSSYLEGQAAKEFIA (Trp-S-FAM)-LVKGR-NH2 |
BDC2.5 Mimotope | RTRPLWVRME |
Biotin-Exendin 4 | Biotin - HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
Biotin-Glucagon (1-29), bovine, human, porcine | Biotin-HSQGTFTSDYSKYLDSRRAQDFVQWLMNT |
Biotin-Glucagon-Like Peptide 1, GLP-1 (7-36), amide, human | Biotin-HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
Exendin (5-39) | TFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
Exendin (9-39) | DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
Exendin 4 | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
Exendin 4, FAM-labeled | FAM-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
Fluorescein-Trp25-Exendin-4 (FLEX) | HGEGTFTSDLSKQMEEEAVRLFIE-(Trp-S-FAM)-LKNGGPSSGAPPPS-NH2 |
GIP (1-42), human | YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ |
GIP (3-42), human | EGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ |
GIP, rat | YAEGTFISDYSIAMDKIRQQDFVNWLLAQKGKKNDWKHNLTQ |
GLP-1(9-36), amide, human | EGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
GLP-2 (1-34), Glucagon-Like Peptide-2 (1-34), human | HADGSFSDEMNTILDNLAARDFINWLIQTKITDR |
Glucagon (1-29), bovine, human, porcine | HSQGTFTSDYSKYLDSRRAQDFVQWLMNT |
Glucagon (1-29), bovine, human, porcine, FAM-labeled | FAM-HSQGTFTSDYSKYLDSRRAQDFVQWLMNT |
Glucagon (1-37), Oxyntomodulin, porcine | HSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNKNNIA |
Glucagon-Like Peptide 1, GLP-1 (7-36), amide, human | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
Glucagon-Like Peptide 1, GLP-1 (7-36)-Lys(Biotin), amide, human | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRK(Biotin)-NH2 |
Glucagon-Like Peptide 1, GLP-1 (7-37) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG |
Glucagon-Like Peptide 1, GLP-1 amide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
Glucagon-Like Peptide 1, GLP-1 amide, human, FAM-labeled | FAM-HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
IGRP Catalytic Subunit-related Protein (206-214) | VYLKTNVFL |
Insulin β Chain Peptide (15-23) | LYLVCGERG |
Insulin B (9-23) | SHLVEALYLVCGERG |
Pancreatic Polypeptide, human | APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 |
Peptide YY (3-36), human | IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 |
Peptide YY, human | YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 |
Trp Cage | NLYIQWLKDGGPSSGRPPPS |
Biotin-Dynorphin A (1-17) | Biotin-YGGFLRRIRPKLKWDNQ |
Dynorphin A (1-17) | YGGFLRRIRPKLKWDNQ |
Dynorphin A (1-8), porcine | YGGFLRRI |
β-Endorphin, human | YGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE |
Autocamtide-2-Related Inhibitory Peptide (AIP); CaMKII Inhibitor, myristoylated | Myr-KKALRRQEAVDAL |
Autocamtide-3 Derived Inhibitory Peptide(AC3-I); CaMKII Inhibitor, myristoylated | Myr-KKALHRQEAVDAL |
Calpain Substrate, Fluorogenic | (Z-AA)2Rh110 |
Cathepsin S Substrate | Ac-KQKLR-AMC |
delta PKC (8-17); PKC d Inhibitor | SFNSYELGSL |
Elastase Substrate, fluorogenic | (Z-AAAA)2Rh110 |
Bid BH3-r8 | rrrrrrrr-GEDIIRNIARHLAQVGDSMDR |
Bim BH3, Peptide III | DMRPEIWIAQELRRIGDEFNAYYAR |
Bim BH3, Peptide IV | DMRPEIWIAQELRRIGDEFNAYYARR |
c-Myc peptide epitope | EQKLISEEDL |
Enhanced Green Fluorescent Protein, EGFP (200-208) | HYLSTQSAL |
G209-2M, gp100 (209-217) | IMDQVPFSV |
GAD65 (206-220) | TYEIAPVFVLLEYVT |
gp100 (25-33), human | KVPRNQDWL |
HIF-1 {alpha} (556-574) | DLDLEMLAPYIPMDDDFQL |
Kisspeptin-10 (Kp-10), Metastin (110-119), amide, mouse, rat | YNWNSFGLRY-NH2 |
Kisspeptin-10 (Kp-10), Metastin (45-54) | YNWNSFGLRF-NH2 |
LyP-1, Peptide 1 | CGNKRTRGC (S-S Bonded) |
MAGE-3 (271-279) | FLWGPRALV |
MUC1, tandem repeat fragment | PDTRPAPGSTAPPAHGVTSA |
MUC5AC, Analog 1 | GTTPSPVPTTSTTSAP |
MUC5AC 3 | GT-T*-PSPVPTTSTTSAP |
MUC5AC-13 | GTTPSPVPTTST-T*-SAP |
MUC5AC-3/13 | GT-T*-PSPVPTTST-T*-SAP |
Noxa A BH3 peptide, cell permeable | rrrrrrrrGAELPPEFAAQLRKIGDKVYC |
Nuclear Factor (Erythroid-derived 2)like 2 (74-87); Nrf2 (74-87); NFE2L2 (74-87) | LQLDEETGEFLPIQ |
Shepherdin (79-87) | KHSSGCAFL |
Thrombospondin-derived Peptide; Cyclic CSVTCG | CSVTCG (S-S Bonded) |
TRP-2 (180-188) | SVYDFFVWL |
TRP-2, Tyrosinase-related Protein 2 (181-188) | VYDFFVWL |
VEGFR2/KDR Antagonist | ATWLPPR |
β-Casomorphin (1-7), bovine | YPFPGPI |
CEF1, Influenza Matrix Protein M1 (58-66) | GILGFVFTL |
CEF2, Influenza Virus PA (46-54) | FMYSDFHFI |
CEF8, Influenza Virus NP (383-391) | SRYWAIRTR |
CEF10, Epstein-Barr Virus LMP2 (426-434) | CLGGLLTMV |
CEF11, Epstein-Barr Virus BMLF1 (280-288) | GLCTLVAML |
CEF19, Epstein-Barr Virus latent NA-3A (458-466) | YPLHEQHGM |
CEF20, Cytomegalovirus, CMV pp65 (495-503) | NLVPMVATV |
CEF25, Influenza Virus NP (44-52) | CTELKLSDY |
CEF26, Influenza Virus NP (265-274) | ILRGSVAHK |
CEF30, Epstein-Barr Virus BRLF1 (134-142) | ATIGTAMYK |
37,43Gap 27, Connexin Mimetic | SRPTEKTIFII |
37, 40 GAP26, Connexin Mimetic | VCYDQAFPISHIR |
40Gap 27, Connexin Mimetic | SRPTEKNVFIV |
43Gap 26, Connexin Mimetic | VCYDKSFPISHVR |
4N1K | KRFYVVMWKK |
Cell Adhesive Peptide [RGDC] | RGDC |
FN-A208 Fusion Peptide | GRGDSGAASIKVAVSADR |
Gap 27, scrambled | REKIITSFIPT |
Hyaluronan Inhibitor | GAHWQFNALTVR |
Hyaluronan-Binding Peptide, biotin labeled | GAHWQFNALTVRGGGS-K(Biotin) |
Vitronectin (367-378) | GKKQRFRHRNRKG |
(Arg)9 | RRRRRRRRR |
(Arg)9 biotin labeled | Biotin-LC-RRRRRRRRR-NH2 |
(Arg)9, FAM-labeled | FAM-RRRRRRRRR |
(Arg)9, TAMRA-labeled | TAMRA-RRRRRRRRR |
Antennapedia Peptide, acid | RQIKIWFQNRRMKWKK |
Antennapedia Peptide, FAM-labeled | 5-FAM-RQIKIWFQNRRMKWKK-NH2 |
Anti-BetaGamma (MPS-Phosducin-like protein C terminus) | AAVALLPAVLLALLAVTDQLGEDFFAVDLEAFLQEFGLLPEKE |
Biotin-TAT (47-57) | Biotin-YGRKKRRQRRR |
Buforin | TRSSRAGLQFPVGRVHRLLRK |
Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) | YTIWMPENPRPGTPCDIFTNSRGKRASNGGGGRRRRRRRRR |
Cys(Npys) Antennapedia Peptide, amide | C(Npys)-RQIKIWFQNRRMKWKK-NH2 |
Cys(Npys)-(Arg)9 | C(Npys)RRRRRRRRR-NH2 |
Cys(Npys)-(D-Arg)9 | C(Npys)rrrrrrrrr-NH2 |
Cys(Npys)-TAT (47-57) | C(Npys)YGRKKRRQRRR-NH2 |
Cys(Npys)-TAT (47-57), FAM-labeled | C(Npys)YGRKKRRQRRR-K(FAM)-NH2 |
Cys-TAT (47-57) | CYGRKKRRQRRR-NH2 |
FITC-LC-Antennapedia Peptide | FITC-LC-RQIKIWFQNRRMKWKK-NH2 |
FITC-LC-TAT (47-57) | FITC-LC-YGRKKRRQRRR-NH2 |
HIV-1 Tat (48-60) | GRKKRRQRRRPPQ |
KALA | WEAKLAKALAKALAKHLAKALAKALKACEA |
Mastoparan | INLKALAALAKKIL-NH2 |
NGR Peptide 1 | CNGRCGGklaklakklaklak-NH2 (Disulfide bridge: 1-5) |
Penetratin | RQIKIWFQNRRMKWKKGG |
Penetratin-Arg | RQIRIWFQNRRMRWRR |
Pep-1-Cysteamine | Ac-KETWWETWWTEWSQPKKKRKV-cysteamine |
Pep-1: Chariot (Non-Covalent Delivery of Peptides and Proteins) | KETWWETWWTEWSQPKKKRKV |
pVEC (Cadherin-5) | LLIILRRRIRKQAHAHSK |
Rabies Virus Glycoprotein (RVG) | YTIWMPENPRPGTPCDIFTNSRGKRASNG |
SV-40 Large T-antigen Nuclear Localization Signal (NLS) | CGGGPKKKRKVED |
SV40 T-Ag-derived Nuclear Localization Signal (NLS) Peptide | PKKKRKVEDPYC |
TAT (47-57) | YGRKKRRQRRR |
TAT (47-57) GGG-Cys(Npys) | YGRKKRRQRRRGGG-C(Npys)-NH2 |
TAT (47-57), FAM-labeled | FAM-YGRKKRRQRRR |
TAT (47-57), TAMRA-labeled | TAMRA-YGRKKRRQRRR |
Tat-Beclin-1 | YGRKKRRQRRRGGTNVFNATFEIWHDGEFGT |
Tat-Beclin-1, scrambled | YGRKKRRQRRRGGVGNDFFINHETTGFATEW |
Tat-C (48-57) | CGRKKRRQRRR |
TAT-GluR23A Fusion Peptide | YGRKKRRQRRRAKEGANVAG |
Tat-GluR23Y | YGRKKRRQRRRYKEGYNVYG |
Tat-GluR23Y, scrambled | YGRKKRRQRRRVYKYGGYNE |
TAT-HA2 Fusion Peptide | RRRQRRKKRGGDIMGEWGNEIFGAIAGFLG |
Tat-NR2Bct | YGRKKRRQRRRKLSSIESDV |
TAT-NSF222 Fusion Peptide | YGRKKRRQRRR-GGG LDKEFNSIFRRAFASRVFPPE |
TAT-NSF222scr Fusion Polypeptide, scrambled | YGRKKRRQRRR-GGG-ENSFRFLADIFPAKAFPVRFE |
TAT-NSF700 Fusion Peptide | YGRKKRRQRRR-GGG-LLDYVPIGPRFSNLVLQALLVL |
TAT-NSF700scr | YGRKKRRQRRRGGGIPPVYFSRLDLNLVVLLLAQL |
TfR Targeting Peptide | THRPPMWSPVWP |
Transdermal Peptide | ACSSSPSKHCG |
Transportan | GWTLNSAGYLLGKINLKALAALAKKIL |
Chemerin (149-157) | YFPGQFAFS |
[Thr28, Nle31]-Cholecystokinin (25-33), sulfated | RD-Y(SO3H)-TGW-Nle-DF-NH2 |
Caerulein | Pyr-QD-Y(SO3H)-TGWMDF-NH2 |
Cholecystokinin (26-33), CCK Octapeptide, CCK-8, sulfated | D-Y(SO3H)-MGWMDF-NH2 |
Calcitonin Gene Related Peptide, CGRP (8-37), human | VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 |
EMP17, FITC-LC labeled | FITC-LC-TYSCHFGPLTWVCKPQGG |
Endothelin 1, human, FAM-labeled | FAM-CSCSSLMDKECVYFCHLDIIW (Disulfide bridge: 1-15 and 3-11) |
Endothelin 1, human, porcine | CSCSSLMDKECVYFCHLDIIW (Disulfide bridge: 1-15 and 3-11) |
Endothelin 3, human, rat | CTCFTYKDKECVYYCHLDIIW (Disulfide bridge: 1-15 and 3-11) |
Erythropoietin-Mimetic Peptide 17 (EMP17) | TYSCHFGPLTWVCKPQGG |
Fibrinogen Binding Inhibitor Peptide | HHLGGAKQAGDV |
Fibrinolysis Inhibiting Factor | GPRP |
Fibrinopeptide A, human | ADSGEGDFLAEGGGVR |
Fibrinopeptide B, human | Pyr-GVNDNEEGFFSAR |
FRETS - VWF73 (Fluorescence-Quenching Substrate for ADAMTS-13) | DRE-Dap(Nma)-APNLVYMVTG-Dpa-PASDEIKRLPGDIQVVPIGVGPNANVQELERIGWPNAPILIQDFETLPREAPDLVLQR |
Gamma - Fibrinogen (377-395) | YSMKETTMKIIPFNRLSIG |
Gamma - Fibrinogen (377-395), scrambled | KMMISYTFPIERTGLISNK |
H-D-Phe-Pro-Arg-AFC | fPR-AFC |
H-D-Val-Leu-Lys-AFC | vLK-AFC |
Hirudin (54-65), sulfated | Ac-GDFEEIPEE-Y(SO3H)-LQ |
HOE I40 | rRP-(Hyp)-G-(Thi)-S-(D-Tic)-(Oic)-R |
LSKL, Inhibitor of Thrombospondin (TSP-1) | LSKL-NH2 |
Neurotensin | Pyr-LYENKPRRPYIL |
Neurotensin (8-13) | RRPYIL |
Proadrenomedullin N - terminal 20 peptide, PAMP (1-20) | ARLDVASEFRKKWNKWALSR-NH2 |
Protease-Activated Receptor-1, PAR-1 Agonist | TFLLRN |
Protease-Activated Receptor-1, PAR-1 Agonist, amide | AF(para-Fluoro)R-Cha-Cit-Y-NH2 |
Protease-Activated Receptor-1, PAR-1 Antagonist | YFLLRNP-OH |
Protease-Activated Receptor-1, PAR-1 Antagonist, amide | S-F(para-Fluoro)-Aad-LRNP-NH2 |
Protease-Activated Receptor-2, PAR-2 Agonist, amide | 2-Furoyl-LIGRLO-NH2 |
Protease-Activated Receptor-2, PAR-2 Agonist, amide | SLIGKV-NH2 |
Protease-Activated Receptor-3 (1-6), PAR-3 (1-6), human | TFRGAP-NH2 |
Protease-Activated Receptor-3, PAR-3 Agonist, amide | SFNGGP-NH2 |
Protease-Activated Receptor-4, PAR-4 Agonist, amide | AYPGKF-NH2 |
Protease-Activated Receptor-4, PAR-4 Agonist, amide, murine | GYPGKF-NH2 |
Protease-Activated Receptor-4, PAR-4 Antagonist, amide | trans-Cinnamoyl-YPGKF-NH2 |
RYR2 (2460-2495) | GFCPDHKAAMVLFLDRVYGIEVQDFLLHLLEVGFLP |
Uroguanylin (Rat) | TDECELCINVACTGC (Disulfide bonds between Cys4-Cys12 and Cys7-Cys15 |
VIP (1-12), human, porcine, rat | HSDAVFTDNYTR |
VIP, human, porcine, rat | HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 |
VIP, human, porcine, rat, FAM-labeled | FAM-HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 |
WP9QY, TNF-alpha Antagonist | YCWSQYLCY (Disulfide bridge: 2-8) |
Linear C5a Receptor Antagonist, human, rat | FKP-(D-Cha)-Wr |
C5a Receptor Agonist, mouse, human | FKP-(D-Cha)-Cha-r |
BMAP-18 | GRFKRFRKKFKKLFKKLS |
BMAP-27 | GRFKRFRKKFKKLFKKLSPVIPLLHLG |
NRC-16 | GWKKWLRKGAKHLGQAAIK |
PMAP-23 | RIIDLLWRVRRPQKPKFVTVWVR |
Rev4 | RRWPWWPWKWPLI |
SMAP-18 | RGLRRLGRKIAHGVKKYG-NH2 |
Tet-20 | KRWRIRVRVIRKC |
Bax BH3 peptide (55-74), wild type | STKKLSECLKRIGDELDSNM |
Biotin-Caspase 1 Inhibitor II | Biotin-YVAD-CMK |
Caspase 1 (ICE) Substrate 2, chromogenic | Ac-YVAD-pNA |
Caspase 1 (ICE) Substrate 3f, fluorogenic | Ac-WEHD-AFC |
Caspase 1 Inhibitor II | Ac-YVAD-CMK |
Caspase 3 (Apopain) Substrate 1, chromogenic | Ac-DEVD-pNA |
Caspase 3 (Apopain) Substrate 1f, fluorogenic | Ac-DEVD-AFC |
Caspase 3 (Apopain) Substrate 1m, fluorogenic | Ac-DEVD-AMC |
Caspase 3 (Apopain) Substrate 1r-z, fluorogenic | (Z-DEVD)2-Rh110 |
Caspase 8 Substrate 1, chromogenic | Ac-IETD-pNA |
Caspase 8 Substrate 1f, fluorogenic | Ac-IETD-AFC |
Caspase 9 Substrate 1, chromogenic | Ac-LEHD-pNA |
Caspase 9 Substrate 1f, fluorogenic | Ac-LEHD-AFC |
Pro-apoptotic Peptide, klaklakklaklak, 5-FAM-labeled | 5-FAM-klaklakklaklak-NH2 |
Proapoptotic Peptide, (klaklak)2 | klaklakklaklak-NH2 |
PUMA BH3 | EEQWAREIGAQLRRMADDLNAQYER |
Smac/Diablo Peptide [AVPIAQKSE], 5-FAM labeled | AVPIAQKSEK-K(5-FAM)-NH2 |
26Rfa, Hypothalamic Peptide, human | TSGPLGNLAEELNGYSRKKGGFSFRF-NH2 |
26Rfa, Hypothalamic Peptide, rat | ASGPLGTLAEELSSYSRRKGGFSFRF-NH2 |
CRAMP1-39 | ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ |
Listeria monocytogenes Listeriolysin O; LLO (91-99) | GYKDGNEYI |
Bacterial Sortase Substrate I, FRET | DABCYL-LPETG-EDANS |
Bacterial Sortase Substrate II , Dabcyl/Edans | Dabcyl-QALPETGEE-Edans |
Bacterial Sortase Substrate III, Abz/DNP | Abz-LPETG-K(Dnp)-NH2 |
CFP10 (71-85) | EISTNIRQAGVQYSR |
CSP-1, Competence Stimulating Peptide-1 | EMRLSKFFRDFILQRKK |
flg22, Flagellin Fragment | QRLSTGSRINSAKDDAAGLQIA |
HCAM-2 | 6-FAM-VFDAVTDVIIKNNLKECGLY |
SPase I FRET Substrate | Dabcyl-AGHDAHASET-Edans |
Staphylococcal Enterotoxin B Domain (SEB) (144-153) | KKKVTAQELD |
bFGF (119-126), Basic Fibroblast Growth Factor, human, bovine | KRTGQYKL |
BAD (103-127), human | NLWAAQRYGRELRRMSDEFVDSFKK |
BAD (103-127), human, FAM-labeled | FAM-NLWAAQRYGRELRRMSDEFVDSFKK |
Noxa BH3, Peptide 1 | PAELEVECATQLRRFGDKLNFRQKLL |
[D-Tyr6, β-Ala11, Phe13, Nle14]-Bombesin (6-14) | yQWAV-(ß-A)-HF-Nle-NH2 |
[Lys3]-Bombesin | Pyr-QKLGNQWAVGHLM-NH2 |
C-peptide (57-87), human | EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ |
C-peptide, dog | EVEDLQVRDVELAGAPGEGGLQPLALEGALQ |
C-Peptide-1, rat | EVEDPQVPQLELGGGPEAGDLQTLALEVARQ |
C-Peptide-2, rat | EVEDPQVAQLELGGGPGAGDLQTLALEVARQ |
Proinsulin C-Peptide (31-63), porcine | RREAENPQAGAVELGGGLGGLQALALEGPPQKR |
Proinsulin C-peptide (55-89), human | RREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKR |
[Trp63, 64]-C3a (63-77) | WWGKKYRASKLGLAR |
C3a (70-77) | ASHLGLAR |
Calcitonin, human | CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (Disulfide bridge: 1-7) |
Calcitonin, salmon | CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP-NH2 (Disulfide bridge: 1-7) |
[Asp370]-Tyrosinase (368-376) | YMDGTMSQV |
AH1 Sequence (6-14) | SPSYVYHQF |
Bak BH3 | GQVGRQLAIIGDDINR |
Bak BH3 peptide, TAMRA-labeled | 5-TAMRA-GQVGRQLAIIGDDINR |
Bcl-2 Binding Peptide, Bad BH3 Peptide | LWAAQRYGRELRRMSDEFEGSFKGL |
Bid BH3 Peptide | EDIIRNIARHLAQVGDSMDR |
Bid BH3, FAM labeled | 5-FAM-EDIIRNIARHLAQVGDSMDR |
Beta-Amyloid (1-33), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIG |
Beta-Amyloid (1-34), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL |
Beta-Amyloid (1-36), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMV |
Beta-Amyloid (1-37), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVG |
Beta-Amyloid (1-38), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGG |
Beta-Amyloid (1-39), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGV |
Beta-Amyloid (3-16), Human | EFRHDSGYEVHHQK |
Beta-Amyloid (10-20), Human | YEVHHQKLVFF |
Beta-Amyloid (10-26), Human | YEVHHQKLVFFAEDVGS |
Beta-Amyloid (10-35)-Lys(Biotin)-NH2, Human | YEVHHQKLVFFAEDVGSNKGAIIGLM-K(Biotin)-NH2 |
Beta-Amyloid (11-17), Human | EVHHQKL |
Beta-Amyloid (11-22), Human | EVHHQKLVFFAE |
Beta-Amyloid (11-25), Human | EVHHQKLVFFAEDVG |
Biotin-LC-beta-Amyloid (15-25), Human, mouse/rat | Biotin-LC-QKLVFFAEDVG |
Beta-Amyloid (16-22), Human, mouse/rat | KLVFFAE |
Beta-Amyloid (17-24), Human, mouse/rat | LVFFAEDV |
Beta-Amyloid (22-35), Human, mouse/rat | EDVGSNKGAIIGLM |
Biotin-LC-beta-Amyloid (22-41), Human, mouse/rat | Biotin-LC-EDVGSNKGAIIGLMVGGVVI |
Beta-Amyloid (25-35), Human, mouse/rat | GSNKGAIIGLM |
Angiotensin (1-7) | DRVYIHP |
Beta-Amyloid (25-35) • HCl, Human, mouse/rat | GSNKGAIIGLM • HCl |
Beta-Amyloid (25-35), scrambled, Human, mouse/rat | MAKGINGISGL |
Biotin-beta-Amyloid (25-35), Human, mouse/rat | Biotin-GSNKGAIIGLM |
Beta-Amyloid (1-28)-Lys(Biotin)-NH2, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNK-K(Biotin) NH2 |
Angiotensin II, human | DRVYIHPF |
Angiotensin II, human, FAM-labeled | FAM-DRVYIHPF |
Angiotensin II, human, TAMRA-labeled | TAMRA-DRVYIHPF |
Biotin-LC-Angiotensin II | Biotin-LC-DRVYIHPF |
Angiotensin II Substrate | DRV-pY-IHPF |
Angiotensin I, human | DRVYIHPFHL |
Angiotensin I Converting Enzyme 2, (ACE-2) Substrate | Mca-APK(Dnp) |
Angiotensin I Converting Enzyme 2, ACE-2/Caspase-1 Substrate | Mca-YVADAPK(Dnp) |
Angiotensin III | RVYIHPF |
Tetradecapeptide Renin Substrate, Angiotensinogen (1-14), rat | DRVYIHPFHLLYYS |
Rat Renin Inhibitor Peptide, WFML Peptide | Ac-HPFV-(Sta)-LF-NH2 |
Renin 390 FRET Substrate I | R-E(EDANS)-IHPFHLVIHT-K(DABCYL)-R |
Calcitonin Gene Related Peptide, CGRP, human | ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 (Disulfide bridge: 2-7) |
C-Type Natriuretic Peptide (32-53), human, porcine | GLSKGCFGLKLDRIGSMSGLGC (Disulfide bridge: 6-22) |
BNP-45, mouse | SQGSTLRVQQRPQNSKVTHISSCFGHKIDRIGSVSRLGCNALKLL (Disulfide bridge:23-39) |
BNP-32, human | SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH (Disulfide bridge: 10-26) |
Biotin-Oxytocin | Biotin-CYIQNCPLG-NH2 (Disulfide bridge: 1-6) |
Big Endothelin-1 (1-38), human | CSCSSLMDKECVYFCHLDIIWVNTPEHVVPYGLGSPRS (Disulfide bridge: 1-15 and 3-11) |
Big Endothelin 1 (1-39), porcine | CSCSSLMDKECVYFCHLDIIWVNTPEHIVPYGLGSPSRS (Disulfide bridge: 1-15 and 3-11) |
Bactenecin, bovine | RLCRIVVIRVCR (Disulfide bridge: 3-11) |
Atrial Natriuretic Peptide (4-18), rat | RSSCFGGRIDRIGAC-NH2 (Disulfide bridge 4-15) |
Atrial Natriuretic Peptide (1-28), rat | SLRRSSCFGGRIDRIGAQSGLGCNSFRY (Disulfide bridge: 7-23) |
Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled | Biotin-SLRRSSCFGGRMDRIGAQSGLGCNSFRY (Disulfide bridge: 7-23) |
Apamin | CNCKAPETALCARRCQQH-NH2 (Disulfide bridge: 1-11; 3-15) |
Atrial Natriuretic Peptide (1-28), human, porcine | SLRRSSCFGGRMDRIGAQSGLGCNSFRY (Disulfide bridge: 7-23) |
Amylin (1-37), human, amide | KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2 (Disulfide bridge: 2-7) |
Amylin (1-37), human | KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY (Disulfide bridge: 2-7) |
Adrenomedullin (1-52), human | YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 (Disulfide bridge: 16-21) |
[Arg8]-Vasopressin (AVP) | CYFQNCPRG-NH2 (Disulfide bridge: 1-6) |
α-Calcitonin Gene Related Peptide, α-CGRP, rat | SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 (Disulfide bridge: 2-7) |
Temporin L, amide | FVQWFSKFLGRIL-NH2 |
Temporin A, amide | FLPLIGRVLSGIL-NH2 |
SMAP 29, Sheep Myeloid Antimicrobial Peptide 29 | RGLRRLGRKIAHGVKKYGPTVLRIIRIAG |
rCRAMP | GLVRKGGEKFGEKLRKIGQKIKEFFQKLALEIEQ |
Pyrrhocoricin | VDKGSYLPRPTPPRPIYNRN |
Protegrine-1 (PG-1), amide | RGGRLCYCRRRFCVCVGR-NH2 (disulfide bridge:6-15 and 8-13) |
mCRAMP, mouse | GLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ |
Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS |
Magainin 1 | GIGKFLHSAGKFGKAFVGEIMKS |
LL17-32 | FKRIVQRIKDFLRNLV |
LL17-29 | FKRIVQRIKDFLR |
LL-37, scrambled | GLKLRFEFSKIKGEFLKTPEVRFRDIKLKDNRISVQR |
LL-37, reverse sequence | SETRPVLNRLFDKIRQVIRKFEKGIKEKSKRFFDGLL |
LL-37, Antimicrobial Peptide, human | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
LL-37 fragment (18-37), LL-18-37 | KRIVQRIKDFLRNLVPRTES |
LEAP-1, Hepcidin, human | DTHFPICIFCCGCCHRSKCGMCCKT (Disulfide bridges: 7-23, 10-13, 11-19, 14-22) |
Lactoferricin B, Lactoferrin (17-41) | FKCRRWQWRMKKLGAPSITCVRRAF (S-S BOND) |
Indolicidin | ILPWKWPWWPWRR-NH2 |
Human Lactotransferrin (37-61), Lactoferricin H | TKCFQWQRNMRKVR-G-PPVSCIKRDS (Disulfide between Cys3 and Cys20) |
Histatin-5 | DSHAKRHHGYKRKFHEKHHSHRGY |
HEL (46-61) | NTDGSTDYGILQINSR |
Drosocin | GKPRPYSPRPTSHPRPIRV |
Dermcidin, DCD-1L | SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSVL |
Cys-LC-LL-37 | C-LC-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
CSP-2, Competence-Stimulating Peptide-2 | EMRISRIILDFLFLRKK |
Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL-NH2 |
Elafin | AQEPVKGPVSTKPGSCPIILIRCAMLNPPNRCLKDTDCPGIKKCCEGSCGMACFVPQ (Disufide bonds between Cys16- Cys45, Cys23-Cys49, Cys32-Cys44, Cys38-Cys53) |
Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-NH2 |
CAP-18, rabbit | GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY |
Biotin-LC-LL-37 | Biotin-LC-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
Bac2A; Bactenecin 2A | RLARIVVIRVAR-NH2 |
Apidaecin IB | GNNRPVYIPQPRPPHPRL |
5-FAM-LC-LL-37 | 5-FAM-LC-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
β-CGRP, human | ACNTATCVTHRLAGLLSRSGGMVKSNFVPTNVGSKAF-NH2 (Disulfide bridge:2-7) |
[Ala13]-Apelin-13 | QRPRLSHKGPMPA |
[Des-Arg10]-HOE I40 | rRP-Hyp-G-Thi-S-(D-Tic)-Oic |
[Des-Pro2]-Bradykinin; Angiotensin I Converting Enzyme (ACE I) Inhibitor | RPPGFSPFR |
[Lys0]-Bradykinin (Kallidin) | KRPPGFSPFR |
[Lys8,9]-Neurotensin (8-13) | KKPYIL |
[Pyr1]-Apelin-13 | Pyr-RPRLSHKGPMPF-OH |
Apelin 12 | RPRLSHKGPMPF |
Apelin-16, human, bovine | FRRQRPRLSHKGPMPF |
Apelin-36, human | LVQPRGSRNGPGPWQGGRRKFRRQRPRLSHKGPMPF |
Biotin-a-CGRP, human | Biotin-LC-ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 (Disulfide bridge:2-7) |
Biotin-Bradykinin | Biotin-RPPGFSPFR |
BNP-45 (51-95), rat, 5K Cardiac Natriuretic Peptide | SQDSAFRIQERLRNSKMAHSSSCFGQKIDRIGAVSRLGCDGLRLF (Disulfide bridge:23-39) |
Sauvagine | Pyr-GPPISIDLSLELLRKMIEIEKQEKEKQQAANNRLLLDTI-NH2 |
Biotin-ACTH (1-39), human | Biotin-SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF |
ACTH (7-38), human | FRWGKPVGKKRRPVKVYPNGAEDESAEAFPLE |
ACTH (18-39), human | RPVKVYPNGAEDESAEAFPLEF |
ACTH (1-39), human | SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF |
ACTH (1-24), human | SYSMEHFRWGKPVGKKRRPVKVYP |
ACTH (1-17) | SYSMEHFRWGKPVGKKR |
ACTH (1-10) | SYSMEHFRWG |
Adrenomedullin (1-50), rat | YRQSMNQGSRSTGCRFGTCTMQKLAHQIYQFTDKDKDGMAPRNKISPQGY-NH2 (Disulfide bridge: 14-19) |
Pramlintide, Acetate [Pro25, 28, 29]-Amylin(1-37), human, Amide | KCNTATCATQRLANFLVHSSNNFGPILPPTNVGSNTY-NH2 (S-S Bond) acetate salt |
Biotin-Amylin (1-37), amide, human | Biotin-KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2 (disulfide bridge: 2-7) |
Amylin (8-37), rat | ATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 |
Amylin (20-29), human | SNNFGAILSS |
Amylin (1-37), rat, mouse | KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 (Disulfide bridge: 2-7) |
[NMeG24, NMeI26] Human Islet Amyloid Polypeptide (IAPP) (22-27) | NF-(NMe-G)-A-(NMe-I)-L |
Beta-Amyloid (13-28), Human | HHQKLVFFAEDVGSNK |
Beta-Amyloid (17-28), Human, mouse/rat | LVFFAEDVGSNK |
[Pro18]-Beta-Amyloid (12-28); V8P Beta-Amyloid (12-28); Aβ12-28P, Human | VHHQKLPFFAEDVGSNK |
Beta-Amyloid (12-28), Human | VHHQKLVFFAEDVGSNK |
Beta-Amyloid (1-28)-Lys(Biotin)-NH2, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNK-K(Biotin)-NH2 |
Beta-Amyloid (1-28), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNK |
Beta-Amyloid (1-40), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Beta-Amyloid (1-40) • HCl, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV • HCl |
Beta-Amyloid (1-40) • HFIP, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV • HFIP |
Beta-Amyloid Peptide (1-40), mouse, rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Scrambled-beta-Amyloid (1-40), Human | AEGDSHVLKEGAYMEIFDVQGHVFGGKIFRVVDLGSHNVA |
Beta-Amyloid (40-1), Human | VVGGVMLGIIAGKNSGVDEAFFVLKQHHVEYGSDHRFEAD |
Biotin-beta-Amyloid (1-40), Human | Biotin-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Biotin-LC-beta-Amyloid (1-40), Human | Biotin-LC-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Beta-Amyloid (1-40)-Lys(Biotin)-NH2, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV-K(Biotin)-NH2 |
Beta-Amyloid (1-40)-Lys(Biotin-LC), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV-K(Biotin-LC) |
Beta-Amyloid (1-40)-Lys(LC-biotin)-NH2, FAM-labeled, Human | 5-FAM-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV-K(LC-BIOTIN)-NH2 |
Beta-Amyloid (1-40)-Lys(Biotin)-NH2, mouse, rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVV-K(Biotin)-NH2 |
Beta-Amyloid (1-40), FAM-labeled, Human | FAM-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Beta-Amyloid (1-40), TAMRA-labeled, Human | TAMRA-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Cys-beta-Amyloid (1-40), Human | CDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Beta-Amyloid (1-40)-Cys, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVC |
[Arg6]-beta-Amyloid (1-40), English Mutation, Human | DAEFRRDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
[Asn7]-beta-Amyloid (1-40), Tottori-Japanese Mutation, Human | DAEFRHNSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
[Gly21]-beta-Amyloid (1-40), A21G, Flemish Mutation, Human | DAEFRHDSGYEVHHQKLVFFGEDVGSNKGAIIGLMVGGVV |
[Gln22]-beta-Amyloid (1-40), Dutch Mutation, Human | DAEFRHDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV |
[Gln22, Asn23]-beta-Amyloid (1-40), E22Q/D23N Dutch/Iowa double mutation, Human | DAEFRHDSGYEVHHQKLVFFAQNVGSNKGAIIGLMVGGVV |
[Gly22]-beta-Amyloid (1-40), Arctic Mutation, Human | DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVV |
[Lys22]-beta-Amyloid (1 - 40), Italian Mutation, Human | DAEFRHDSGYEVHHQKLVFFAKDVGSNKGAIIGLMVGGVV |
[Asn23]-beta-Amyloid (1-40), Iowa Mutation, Human | DAEFRHDSGYEVHHQKLVFFAENVGSNKGAIIGLMVGGVV |
[Cys26]-beta-Amyloid (1-40), S26C beta-Amyloid (1-40), Human | DAEFRHDSGYEVHHQKLVFFAEDVGCNKGAIIGLMVGGVV |
Beta-Amyloid (2-40), Human | AEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Beta-Amyloid (3-40), Human | EFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
[Pyr3]-beta-Amyloid (3-40), Human | Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Beta-Amyloid (11-40), Human | EVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Beta-Amyloid (11-40), FAM-labeled, Human | 5-FAM-EVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Beta-Amyloid (17-40), Human, mouse/rat | LVFFAEDVGSNKGAIIGLMVGGVV |
Biotin-beta-Amyloid (17-40), Human, mouse/rat | Biotin-LVFFAEDVGSNKGAIIGLMVGGVV |
Beta-Amyloid (1-40) Binding Peptide, Biotin-labeled | Biotin-DWGKGGRWRLWPGASGKTEA |
Beta-Amyloid (1-42), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid (1-42) • HCl, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA • HCl |
Biotin-beta-Amyloid (1-42), Human | Biotin-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Biotin-LC-beta-Amyloid (1-42), Human | Biotin-LC-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid (1-42)-Lys(Biotin)-NH2, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-K(Biotin)-NH2 |
Beta-Amyloid (1-42) • HFIP, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA • HFIP |
Beta-Amyloid (1-42), sodium salt, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid Peptide (1-42), mouse, rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Cys-beta-Amyloid (1-42), Human | CDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Scrambled-beta-Amyloid (1-42), Human | AIAEGDSHVLKEGAYMEIFDVQGHVFGGKIFRVVDLGSHNVA |
Beta-Amyloid (1-42), Scrambled, 5-FAM labeled, Human | 5-FAM-AIAEGDSHVLKEGAYMEIFDVQGHVFGGKIFRVVDLGSHNVA |
Beta-Amyloid (42-1), Human | AIVVGGVMLGIIAGKNSGVDEAFFVLKQHHVEYGSDHRFEAD |
Beta-Amyloid (1-42), FAM-labeled, Human | FAM-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
[Met]-beta-Amyloid (1-42), 5-TAMRA labeled, Human | 5-TAMRA-MDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
[Arg6]-beta-Amyloid (1-42), English Mutation, Human | DAEFRRDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
[Asn7]-beta-Amyloid (1-42), Tottori-Japanese Mutation, Human | DAEFRHNSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
[Pro19]-beta-Amyloid (1-42); F19P beta-Amyloid (1-42), Human | DAEFRHDSGYEVHHQKLVPFAEDVGSNKGAIIGLMVGGVVIA |
[Gly21]-beta-Amyloid (1-42), A21G Flemish Mutation, Human | DAEFRHDSGYEVHHQKLVFFGEDVGSNKGAIIGLMVGGVVIA |
[Gln22]-beta-Amyloid (1-42), E22Q Dutch Mutation, Human | DAEFRHDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVVIA |
[Gly22]-beta-Amyloid (1-42), E22G Arctic Mutation, Human | DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVVIA |
[Lys22]-beta-Amyloid (1-42), Italian Mutation, Human | DAEFRHDSGYEVHHQKLVFFAKDVGSNKGAIIGLMVGGVVIA |
[Asn23]-beta-amyloid (1-42), Iowa Mutation, Human | DAEFRHDSGYEVHHQKLVFFAENVGSNKGAIIGLMVGGVVIA |
[Cys26]-beta-Amyloid (1-42), S26C beta-Amyloid (1-42), Human | DAEFRHDSGYEVHHQKLVFFAEDVGCNKGAIIGLMVGGVVIA |
[Met(O)35]-beta-Amyloid (1-42), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-M(O)-VGGVVIA |
Beta-Amyloid (2-42), Human | AEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid (3-42), Human | EFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
[Pyr3]-beta-Amyloid (3-42), Human | Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid (4-42), Human | FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid (5-42), Human | RHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid (9-42), Human | GYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid (11-42), Human | EVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
[Pyr11]-beta-Amyloid (11-42), Human | Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid (20-42), Human, mouse/rat | FAEDVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid (22-42), Human, mouse/rat | EDVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid (23-42), Human, mouse/rat | DVGSNKGAIIGLMVGGVVIA |
Beta-Amyloid (1-9), Human | DAEFRHDSG |
Beta-Amyloid (1-10), Human | DAEFRHDSGY |
Beta-Amyloid (1-11), Human | DAEFRHDSGYE |
Beta-Amyloid (1-12), Human | DAEFRHDSGYEV |
Beta-Amyloid (1-13), Human | DAEFRHDSGYEVH |
Beta-Amyloid (1-15), Human | DAEFRHDSGYEVHHQ |
Beta-Amyloid (1-16), Human | DAEFRHDSGYEVHHQK |
Beta-Amyloid (1-16)-Lys(Biotin-LC)-NH2, Human | DAEFRHDSGYEVHHQK-K(Biotin-LC)-NH2 |
Beta-Amyloid (1-17), Human | DAEFRHDSGYEVHHQKL |
Beta-Amyloid (1-17)-Cys, Human | DAEFRHDSGYEVHHQKLC |
Beta-Amyloid (1-22), Human | DAEFRHDSGYEVHHQKLVFFAE |